{"study_id": 71500, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential of substituting glucose with alternative osmotic agents in peritoneal dialysis fluids to reduce metabolic abnormalities and preserve peritoneal membrane function.", "results_summary": "The abstract does not provide specific results regarding L-Carnitine; it focuses on the design of a clinical trial (ELIXIR) comparing Xylocore as an alternative osmotic agent.", "population_specificity": "Patients undergoing peritoneal dialysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:00.836223+00:00"}
{"study_id": 71501, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of peritoneal ultrafiltration with PolyCore\u2122 in patients with refractory congestive heart failure (RCHF).", "results_summary": "The study is designed to assess the impact of PolyCore\u2122 on a composite endpoint of mortality or worsening patient condition, but results are not yet available as the trial is about to start.", "population_specificity": "Patients with refractory congestive heart failure (RCHF) presenting with right ventricular failure, functional tricuspid regurgitation, and enlarged cava vein due to fluid overload.", "effective_dosage": "Not mentioned", "study_duration": "Up to 12 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:01.105137+00:00"}
{"study_id": 71504, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether L-Carnitine, combined with other interventions, could reduce intrahepatocellular triglyceride content and improve liver function during normothermic machine perfusion, potentially making steatotic livers suitable for transplantation.", "results_summary": "The study found that L-Carnitine, in combination with forskolin and lipoprotein apheresis, reduced intrahepatocellular triglyceride content and improved liver function during perfusion, suggesting potential suitability for transplantation. However, the abstract does not isolate L-Carnitine's individual effects.", "population_specificity": "Discarded steatotic human livers not suitable for transplantation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:02.814032+00:00"}
{"study_id": 71503, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the effects of a whey protein hydrolysate containing AJI-801 (a decapeptide) on blood acetyl-L-carnitine (ALC) levels and mood status in fatigued individuals.", "results_summary": "The study found no significant changes in blood ALC or FGF21 levels after WPH intake, but the 500-mg dose significantly improved mood status, particularly reducing feelings of depression.", "population_specificity": "Healthy individuals aged 20-59 years with fatigue.", "effective_dosage": "100 mg and 500 mg of WPH (containing 2.5 mg AJI-801 in the 500-mg dose).", "study_duration": "Single intake with measurements taken up to 180 minutes post-consumption.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:02.819308+00:00"}
{"study_id": 71505, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of L-Carnitine in managing cancer-related fatigue (CRF) in adult cancer survivors.", "results_summary": "The study found that L-Carnitine did not improve CRF during or after cancer treatment, and clinicians were advised not to recommend it for managing CRF symptoms.", "population_specificity": "Adult survivors of cancer experiencing cancer-related fatigue.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:03.592125+00:00"}
{"study_id": 71507, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether L-Carnitine could improve persistent hypothyroid symptoms in patients with biochemical euthyroidism on thyroid hormone replacement.", "results_summary": "The study found inconsistent improvement in hypothyroidism-related symptoms with L-Carnitine compared to placebo, with no clear, significant benefits reported.", "population_specificity": "Adult patients (78.6% female, mean age 47.5 \u00b1 2.8 years) with persistent hypothyroid symptoms despite normal thyroid hormone levels.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:07.071532+00:00"}
{"study_id": 71508, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the role of acetyl-L-carnitine in treating neuropathic pain, particularly in the context of diabetic neuropathy and other causes of peripheral neuropathy.", "results_summary": "The abstract suggests that acetyl-L-carnitine is among the symptomatic treatments for neuropathic pain, alongside tricyclic antidepressants and anticonvulsants, but does not provide specific efficacy data.", "population_specificity": "Patients with peripheral neuropathy, including diabetic neuropathy, chemotherapy-induced neuropathy, autoimmune-related neuropathy, and chronic ethanol intake-related neuropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:10.473323+00:00"}
{"study_id": 71511, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of L-Carnitine among 12 antioxidant therapies for improving ADHD symptoms in children and adolescents.", "results_summary": "The abstract does not provide specific findings for L-Carnitine's safety or efficacy, as it was one of 12 antioxidants included in the network meta-analysis without detailed results.", "population_specificity": "Children and adolescents with ADHD.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:10.831033+00:00"}
{"study_id": 71517, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to review the potential of L-Carnitine as a nutraceutical option for migraine treatment among other supplements and dietary interventions.", "results_summary": "The abstract mentions L-Carnitine as one of the discussed supplements for migraine, but no specific findings or evidence regarding its effectiveness are detailed.", "population_specificity": "Migraine patients (general, no specific subgroup mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:11.339101+00:00"}
{"study_id": 71513, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effects of L-carnitine on inflammation, oxidative stress, and clinical outcomes in critically ill septic patients.", "results_summary": "L-carnitine significantly reduced inflammatory markers (CRP, ESR), improved antioxidant defense (SOD, TAC), and lowered the 28-day mortality rate compared to placebo. It also improved clinical parameters like serum albumin and platelet counts.", "population_specificity": "Critically ill septic patients", "effective_dosage": "3 g/day", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:11.531523+00:00"}
{"study_id": 71512, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolite signatures, including L-Carnitine, associated with bladder cancer (BCa) to improve molecular classification and potential biomarker discovery.", "results_summary": "The study found increased concentrations of L-Carnitine in BCa-associated metabolite signatures, suggesting its potential role as part of a BCa metabolome profile. However, the biological significance and clinical validation of L-Carnitine in BCa remain to be explored.", "population_specificity": "Bladder cancer patients and associated biological samples (urine, tumor tissue, cell line cultures).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:11.628752+00:00"}
{"study_id": 71518, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of L-carnitine, acetyl-L-carnitine, vitamins, and other nutrients on semen quality in infertile patients with or without varicocele, while also assessing the impact of age and obesity.", "results_summary": "Supplementation significantly improved sperm concentration, total sperm count, and motility compared to placebo. The treatment was more effective in patients under 35 years with normal weight, while obesity negatively impacted sperm concentration.", "population_specificity": "104 infertile male patients with or without varicocele.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:14.941382+00:00"}
{"study_id": 71522, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review scientific evidence for treating NAFLD in pediatric populations, including lifestyle and nutritional interventions.", "results_summary": "The abstract does not specifically mention L-Carnitine or its effects on NAFLD.", "population_specificity": "Pediatric population with obesity and NAFLD.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:16.819000+00:00"}
{"study_id": 71527, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the effects of LC and LAC on brain damage caused by obesity, focusing on mitochondrial dysfunction and oxidative stress.", "results_summary": "The study found that LC and LAC may help recover REDOX status and mitochondrial dysfunction in the CNS in obesity, suggesting potential as a treatment. However, further research is needed to clarify the molecular mechanisms.", "population_specificity": "Individuals with obesity-related brain damage and mitochondrial dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:18.288273+00:00"}
{"study_id": 71528, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effectiveness of various antioxidants, including L-Carnitine, in improving seminal parameters in men with idiopathic oligo-astheno-teratozoospermia (OAT).", "results_summary": "L-Carnitine, particularly in combination with L-acetyl-carnitine (LAC), showed the highest efficacy for improving sperm concentration, progressive motility, and morphology compared to placebo. It outperformed other antioxidants in these outcomes.", "population_specificity": "Men with idiopathic OAT (mean age: 33.5 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:19.259535+00:00"}
{"study_id": 71529, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of L-Carnitine as a nutritional intervention for reducing exercise-induced muscle damage (EIMD) outcomes, such as postexercise creatine kinase levels and muscle soreness.", "results_summary": "The study found that L-Carnitine supplementation significantly reduced postexercise creatine kinase levels and muscle soreness, with moderate certainty of evidence. It was among the interventions showing favorable effects on EIMD-related outcomes.", "population_specificity": "Individuals experiencing exercise-induced muscle damage (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:19.783530+00:00"}
{"study_id": 71530, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether adding omega-3 and Manuka honey to conventional therapy (including L-Carnitine) improved oxidative stress management in pediatric \u03b2-thalassemia major patients.", "results_summary": "The study found that omega-3 and Manuka honey combined with conventional therapy (including L-Carnitine) significantly reduced oxidative stress markers (8-iso-PGF2\u03b1, LDH) and improved lipid profiles compared to conventional therapy alone or Manuka honey alone. L-Carnitine's specific effects were not isolated in the results.", "population_specificity": "Pediatric patients with \u03b2-thalassemia major.", "effective_dosage": "Not specified for L-Carnitine (part of conventional therapy).", "study_duration": "10 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:20.896710+00:00"}
{"study_id": 71515, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effects of L-Carnitine, among other nutritional interventions, on preventing and treating pressure ulcers compared to a standard diet.", "results_summary": "The evidence is very uncertain about the effects of L-Carnitine (combined with L-leucine, calcium, magnesium, and vitamin D) on pressure ulcer incidence when compared to a standard diet, based on very low-certainty evidence from a single study.", "population_specificity": "People with or without existing pressure ulcers, including older, immobile individuals, those with diabetes, vascular disease, or malnutrition, and those requiring intensive or palliative care.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:22.046071+00:00"}
{"study_id": 71531, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of ALCAR on survival, functional decline, and self-sufficiency in subjects with ALS.", "results_summary": "ALCAR 3 g/day showed no significant survival benefit, while ALCAR 1.5 g/day was associated with improved survival (71.1% vs. 48.9%) and a slower decline in ALSFRS-R scores, though other measures (FVC, self-sufficiency) showed no significant differences.", "population_specificity": "Subjects with ALS in Italy, matched by sex, age at diagnosis, site of onset, and time from diagnosis.", "effective_dosage": "1.5 g/day or 3 g/day.", "study_duration": "24 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:24.337512+00:00"}
{"study_id": 71533, "supplement_id": 1266, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate L-carnitine as a safe, effective, and inexpensive adjuvant therapy for long-term management of COPD, focusing on its metabolic and muscle bioenergetic benefits.", "results_summary": "The study suggests L-carnitine may improve skeletal muscle dysfunction and metabolic abnormalities in COPD patients, potentially enhancing symptoms, functional activities, and overall disease outcomes. It advocates for broader research and implementation of L-carnitine as a non-toxic, natural therapeutic option.", "population_specificity": "COPD patients with systemic manifestations such as cachexia, muscle weakness, and comorbidities like cardiovascular diseases and diabetes.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:25.056723+00:00"}
{"study_id": 71535, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolites under genetic control that predict ALT elevation due to therapeutic acetaminophen use, including L-Carnitine.", "results_summary": "L-Carnitine was identified as one of eight metabolites under genetic control and predictive of ALT elevation in patients taking therapeutic doses of acetaminophen, suggesting its role in mitochondrial energy production and liver injury pathways.", "population_specificity": "Patients administered 4 g of acetaminophen per day for 14 days or longer.", "effective_dosage": "Not specified for L-Carnitine (study focused on acetaminophen dosage).", "study_duration": "14 days or longer.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:26.486869+00:00"}
{"study_id": 71538, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the molecular profile, tolerability, and clinical potential of acetyl L-carnitine (ALCAR) in managing neurodegeneration, particularly ALS.", "results_summary": "The study suggests ALCAR provides mitochondrial support, reduces oxidative stress, and improves synaptic transmission, indicating potential benefits for neurodegenerative diseases like ALS. However, specific clinical outcomes or statistical significance are not detailed in the abstract.", "population_specificity": "Focus on neurodegenerative diseases, particularly ALS, but no specific patient demographics or sample size mentioned.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:29.249179+00:00"}
{"study_id": 71537, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if L-Carnitine supplementation could counteract muscle-wasting effects of glucocorticoid therapy in pemphigus vulgaris patients.", "results_summary": "L-Carnitine supplementation significantly increased IGF-1 and reduced myostatin levels, suggesting improved muscle metabolism and regeneration, though inter-group differences in IGF-1 and creatine kinase were not significant. It also prevented the myogenin decrease observed in the placebo group.", "population_specificity": "44 pemphigus vulgaris patients aged 30-65 years receiving glucocorticoid therapy.", "effective_dosage": "2 g/day", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:29.390187+00:00"}
{"study_id": 71539, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the effectiveness of nutritional therapies, including L-Carnitine, in treating male infertility/subfertility and rank their efficacy based on type and etiology.", "results_summary": "L-Carnitine, particularly when combined with micronutrients, showed statistically and clinically significant improvements in sperm quality and pregnancy rates, with a risk ratio of 3.60 for pregnancy rates. It was especially effective in men with oligozoospermia, oligoasthenozoospermia, and asthenoteratozoospermia.", "population_specificity": "Adult men with proven infertility or subfertility.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:32.173853+00:00"}
{"study_id": 71510, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers explored pharmacological treatments for sarcopenia in cirrhosis, including existing drugs and ongoing trials, but did not specifically focus on L-Carnitine.", "results_summary": "The abstract does not mention L-Carnitine or its effects, focusing instead on Branched-Chain Amino Acids and general treatment recommendations.", "population_specificity": "Patients with liver cirrhosis and sarcopenia.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:32.381969+00:00"}
{"study_id": 71541, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The abstract does not specifically mention L-Carnitine, so the study goal regarding L-Carnitine cannot be determined.", "results_summary": "The abstract does not provide results specific to L-Carnitine.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not provided.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:33.118088+00:00"}
{"study_id": 71542, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether adding L-Carnitine to risperidone improves symptoms in children and adolescents with autism spectrum disorder (ASD).", "results_summary": "L-Carnitine add-on therapy reduced total ABC scores and subscale scores (restlessness, lethargy, social isolation, stereotypic behavior, and inappropriate speech) at weeks 4 and 8, with significant differences in total ABC and lethargy/social isolation subscales between groups.", "population_specificity": "Children and adolescents with autism spectrum disorder (ASD)", "effective_dosage": "Not specified", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:34.024221+00:00"}
{"study_id": 71540, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the dietary management and outcomes of patients with HMGCL deficiency, including the use of L-Carnitine as part of long-term treatment.", "results_summary": "Most patients with HMGCL deficiency in the study took L-Carnitine as part of their long-term dietary management, which was well tolerated. The study did not report specific efficacy outcomes for L-Carnitine but noted its common use in the cohort.", "population_specificity": "Patients with HMGCL deficiency (10 patients, including children and adults).", "effective_dosage": "Not specified", "study_duration": "Long-term (lifespan follow-up)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:34.284627+00:00"}
{"study_id": 71543, "supplement_id": 1266, "safety_score": "85", "efficacy_score": 90, "quality_score": 95, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and efficacy of a combined metabolic activator (CMA) containing L-Carnitine tartrate in improving cognitive function and metabolic parameters in Alzheimer's disease patients.", "results_summary": "The study found that CMA, including L-Carnitine tartrate, significantly improved cognitive function (29% improvement in ADAS-Cog scores) and metabolic markers in AD patients, with notable changes in hippocampal volumes and cortical thickness. Plasma levels of proteins and metabolites linked to NAD+ and glutathione metabolism were also significantly enhanced.", "population_specificity": "Alzheimer's disease patients", "effective_dosage": "3.73 g L-carnitine tartrate (18.65% of one-dose CMA), administered once daily for the first 28 days and twice daily from day 28 to day 84", "study_duration": "84 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:36.242600+00:00"}
{"study_id": 71545, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the biosynthesis, metabolism, bioavailability, biological actions, and effects of carnitine on various body systems and COVID-19.", "results_summary": "L-Carnitine supports immunological function in diabetic patients, aids in treating Alzheimer's disease, painful neuropathies, heart disease, obesity, and reduces blood glucose levels. It also shows potential to mitigate fatigue in COVID-19.", "population_specificity": "Diabetic patients, individuals with Alzheimer's disease, painful neuropathies, heart disease, obesity, and COVID-19 patients.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:37.328563+00:00"}
{"study_id": 71544, "supplement_id": 1266, "safety_score": "70", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to compare the effectiveness and safety of L-Carnitine in combination with hydroxyurea versus hydroxyurea alone for reducing blood transfusion needs and improving hemoglobin levels in people with non-transfusion-dependent \u03b2-thalassaemia (NTD\u03b2T).", "results_summary": "The study found uncertain evidence that hydroxyurea plus L-Carnitine may increase mean hemoglobin and reduce pulmonary hypertension compared to hydroxyurea alone, but the certainty of evidence was very low. Adverse events were reported but not specifically in the L-Carnitine intervention group.", "population_specificity": "People with non-transfusion-dependent \u03b2-thalassaemia (NTD\u03b2T), aged 2 to 49 years.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:38.225100+00:00"}
{"study_id": 71546, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of L-carnitine adjunctive therapy on nutritional status monitoring variables in critically ill patients.", "results_summary": "L-Carnitine supplementation significantly improved serum albumin, total protein, calcium, and reduced ALT, lactate, creatinine, and INR compared to the control group.", "population_specificity": "Critically ill patients aged >18 years in a medical ICU.", "effective_dosage": "3 g L-carnitine per day.", "study_duration": "1 week.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:39.309877+00:00"}
{"study_id": 71548, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review dietary supplements, including L-Carnitine, for their potential to improve symptoms in patients with post-COVID syndrome.", "results_summary": "A supplement containing hydroxytyrosol, acetyl L-carnitine, and vitamins B, C, and D improved symptoms in patients with post-COVID syndrome, though specific effects of L-Carnitine alone were not detailed.", "population_specificity": "Patients with post-COVID syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:41.208900+00:00"}
{"study_id": 71549, "supplement_id": 1266, "safety_score": "75", "efficacy_score": 45, "quality_score": 68, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of carnitine supplementation for treating dialysis-related complications in CKD patients requiring dialysis.", "results_summary": "L-Carnitine may slightly improve anemia-related markers (hemoglobin and hematocrit) but has little or no effect on quality of life, fatigue, adverse events, muscle cramps, or intradialytic hypotension. The evidence is of low certainty and should be interpreted cautiously.", "population_specificity": "Chronic kidney disease (CKD) patients requiring dialysis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:41.234493+00:00"}
{"study_id": 71547, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to assess whether adding L-carnitine to conventional treatment improves outcomes in acute aluminum phosphide poisoning.", "results_summary": "L-carnitine improved clinical and biochemical markers (e.g., cytochrome c oxidase, caspase-3, caspase-9) and reduced mechanical ventilation needs and mortality compared to the control group.", "population_specificity": "96 individuals with acute aluminum phosphide poisoning (mean age ~26 years, evenly distributed genders, mostly rural, all suicide attempts).", "effective_dosage": "Not specified", "study_duration": "12 hours post-admission (intervention duration not explicitly stated)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:41.617728+00:00"}
{"study_id": 71550, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore mitochondrial-based therapeutic advances, including the potential role of acetyl-L-carnitine in protecting mitochondrial function after spinal cord injury.", "results_summary": "The abstract suggests that acetyl-L-carnitine is among the drugs discussed for mitochondrial protection, but specific efficacy results for L-carnitine are not detailed. The review broadly highlights mitochondrial-based therapies as promising for spinal cord injury recovery.", "population_specificity": "Spinal cord injury patients (theoretical or preclinical context, as the abstract does not specify human trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:43.418980+00:00"}
{"study_id": 71551, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-carnitine reduces 28-day mortality in adult septic shock patients compared to placebo or usual care.", "results_summary": "The study found low-quality evidence that L-carnitine has no significant effect on reducing 28-day mortality in septic shock patients, with a risk difference of -0.03 (95% CI: -0.15\u20130.10).", "population_specificity": "Hospitalized adult septic shock patients (>18 years old).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:43.536540+00:00"}
{"study_id": 71552, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of L-carnitine in combination with magnesium for treating non-alcoholic fatty liver disease (NAFLD).", "results_summary": "The study found that L-carnitine with magnesium reduced AST and ALT levels by 25% and 20%, respectively, but did not affect CRP levels, insulin levels, lipid profile, or liver stiffness.", "population_specificity": "22 participants with NAFLD.", "effective_dosage": "2 grams L-carnitine and 150 mg magnesium (CIRRHOS product).", "study_duration": "16 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:44.770849+00:00"}
{"study_id": 71553, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 50, "study_goal": "The researchers aimed to review current treatment modalities for valproic acid toxicity, including the use of L-carnitine.", "results_summary": "The study reported a case where L-carnitine was used exclusively to treat hyperammonemia resulting from valproic acid overdose, suggesting its potential efficacy in such scenarios. However, the abstract also notes that recent literature supports carbapenem antibiotics as an alternative treatment.", "population_specificity": "A 56-year-old man with intentional valproic acid overdose and hyperammonemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:46.503160+00:00"}
{"study_id": 71554, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "To investigate whether L-carnitine supplementation improves weight gain, reduces hospital stay duration, and ameliorates environmental enteric dysfunction (EED) biomarkers in children with severe acute malnutrition (SAM).", "results_summary": "The study is ongoing, but the hypothesis is that L-carnitine supplementation for 15 days will improve weight gain and EED biomarkers in children with SAM.", "population_specificity": "Diarrheal children aged 9-24 months with severe acute malnutrition attending a nutritional rehabilitation unit in Bangladesh.", "effective_dosage": "Not specified", "study_duration": "15 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:46.620662+00:00"}
{"study_id": 71556, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine if antioxidants, including L-Carnitine, could prevent noise-induced hearing loss (NIHL).", "results_summary": "The abstract does not provide specific results regarding L-Carnitine's effects, only suggesting antioxidants as a potential option for preventing NIHL.", "population_specificity": "Not specified (general mention of adolescent population at risk for NIHL).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:48.435377+00:00"}
{"study_id": 71555, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine the effectiveness of L-carnitine supplementation for improving metabolic and reproductive outcomes in women with PCOS.", "results_summary": "The study found low to moderate certainty evidence that L-carnitine improves BMI and serum lipid levels (LDL, TG, total cholesterol) in women with PCOS, with one comparison group showing reduced fasting plasma glucose.", "population_specificity": "Women with polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:49.098671+00:00"}
{"study_id": 71557, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effect of Acetyl-L-carnitine (ALCAR) on prefrail older patients, focusing on markers of inflammation, cognitive function, and physical performance.", "results_summary": "ALCAR treatment significantly reduced CRP levels, increased serum-free carnitine and acetylcarnitine, improved Mini-Mental State Examination (MMSE) scores, and enhanced 6-minute walking distance compared to placebo. The treated group also showed decreased HDL cholesterol and CRP levels, with notable improvements in cognitive and physical performance.", "population_specificity": "Prefrail older patients", "effective_dosage": "1.5 g twice daily (BID)", "study_duration": "3 months of treatment followed by 3 months of follow-up", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:51.244963+00:00"}
{"study_id": 71559, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the influence of oral Acetyl-L-carnitine (ALC) on functional and neurological outcomes in patients with acute ischemic stroke.", "results_summary": "ALC treatment significantly improved NIHSS and mRS scores compared to placebo, suggesting benefits in functional and neurological recovery, likely due to anti-inflammatory and antioxidant effects.", "population_specificity": "Patients with acute ischemic stroke (symptom onset <24 hours) not eligible for reperfusion therapy.", "effective_dosage": "1000 mg three times per day", "study_duration": "3 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:52.251234+00:00"}
{"study_id": 71560, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore whether combination therapy of phosphodiesterase type 5 inhibitors and L-Carnitine could have synergistic effects in improving erectile dysfunction in diabetic men.", "results_summary": "The study suggests that L-Carnitine, when combined with phosphodiesterase type 5 inhibitors, may have synergistic effects leading to better outcomes in diabetic men with erectile dysfunction. However, specific efficacy data or statistical significance for L-Carnitine alone were not detailed.", "population_specificity": "Diabetic men with erectile dysfunction refractory to phosphodiesterase type 5 inhibitors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:53.532382+00:00"}
{"study_id": 71558, "supplement_id": 1266, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential benefits of L-carnitine supplementation in patients with mild-to-moderate COVID-19.", "results_summary": "L-carnitine supplementation improved O2 saturation, reduced inflammatory markers (ESR, CRP), and lowered enzyme levels (ALP, LDH, CPK). No deaths occurred in the intervention group, while 14% of the control group died.", "population_specificity": "75 hospitalized patients with mild-to-moderate COVID-19 in Iran.", "effective_dosage": "3000 mg oral L-carnitine daily in three divided doses.", "study_duration": "5 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:54.370730+00:00"}
{"study_id": 71564, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of acylcarnitines as diagnostic markers for fatty acid oxidation disorders and their potential as indicators of energy metabolism and mitochondrial/peroxisomal deficits.", "results_summary": "The abstract does not provide specific findings about L-Carnitine's effects, only mentioning its metabolites' roles in cellular energy pathways and their diagnostic utility.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:55.503700+00:00"}
{"study_id": 71563, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of \u03b1-lipoyl-L-carnitine in treating eye diseases linked to mitochondrial dysfunction, including age-related macular degeneration, diabetic retinopathy, glaucoma, and retinopathy of prematurity.", "results_summary": "The study suggests that \u03b1-lipoyl-L-carnitine, a mitochondria-targeting prodrug, shows potential in protecting against retinal degeneration and photoreceptor cell loss in various ophthalmic conditions. The abstract highlights its bioavailable nature but does not provide detailed clinical outcomes.", "population_specificity": "Individuals with mitochondrial dysfunction-related eye diseases (e.g., age-related macular degeneration, diabetic retinopathy, glaucoma, retinopathy of prematurity).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:55.801385+00:00"}
{"study_id": 71562, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of L-carnitine versus CoQ10 and Vitamin E on sperm parameters and hormonal levels in patients with asthenozoospermia and teratozoospermia.", "results_summary": "L-carnitine significantly improved sperm count, progressive motility, morphology, testosterone, and LH levels, outperforming CoQ10 and Vitamin E, which only improved motility, morphology, and testosterone.", "population_specificity": "Patients with asthenozoospermia and teratozoospermia.", "effective_dosage": "15 g/bag, orally one bag at a time, twice a day.", "study_duration": "Three months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:55.823536+00:00"}
{"study_id": 71565, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of L-Carnitine supplementation on clinical status, inflammatory markers, and mortality rate in critically ill ICU patients.", "results_summary": "L-Carnitine significantly reduced CRP and IL-6 levels, improved SOFA and APACHE scores, and showed beneficial effects on inflammatory and clinical outcomes compared to placebo.", "population_specificity": "Critically ill patients admitted to the ICU.", "effective_dosage": "3000 mg/day administered via nasogastric tube.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:56.025306+00:00"}
{"study_id": 71566, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the evidence on novel pharmacotherapeutics, including acetyl-L-carnitine, for chronic non-cancer pain management.", "results_summary": "The abstract mentions developing evidence on acetyl-L-carnitine but does not provide specific findings regarding its efficacy or safety.", "population_specificity": "Not specified (general chronic non-cancer pain patients implied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:58.547924+00:00"}
{"study_id": 71567, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the potential effect of abrocitinib on drug transporters and probe substrates, not L-Carnitine.", "results_summary": "The study did not investigate L-Carnitine; it focused on abrocitinib's inhibition of transporters like P-gp, BCRP, OAT3, OCT1, and MATE1/2K.", "population_specificity": "Healthy participants", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:18:59.479219+00:00"}
{"study_id": 71568, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of acetyl-L-carnitine and other agents in improving chemotherapy-induced peripheral neuropathy (CIPN) and maintaining chemotherapy continuity.", "results_summary": "The abstract suggests that acetyl-L-carnitine, among other agents, could offer a new approach to treating CIPN, potentially improving patient quality of life and chemotherapy adherence, but it does not provide specific efficacy data for L-carnitine alone.", "population_specificity": "Patients with chemotherapy-induced peripheral neuropathy (CIPN).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:02.035215+00:00"}
{"study_id": 71569, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of very high doses of L-carnitine (3000 mg/day) on inflammatory factors, oxidative stress, and clinical outcomes in ICU patients with sepsis.", "results_summary": "The study suggests that L-carnitine may reduce inflammation and oxidative stress, potentially improving clinical outcomes in sepsis patients, though final results on mortality and specific biomarker changes are pending.", "population_specificity": "60 ICU patients with sepsis, aged 20-65 years, from Al-Zahra Hospital, Isfahan, Iran.", "effective_dosage": "3000 mg/day (three 1000 mg capsules) for 7 days.", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:02.652739+00:00"}
{"study_id": 71573, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the biological targets of L-carnitine, its effects on immune function, and its potential benefits for critically ill patients, particularly in sepsis/septic shock management.", "results_summary": "L-carnitine supplementation showed beneficial effects on immune regulation, reduced vasopressor requirements in septic shock, and improved clinical outcomes. However, optimal dosage and duration require further clinical data.", "population_specificity": "Critically ill patients, particularly those with sepsis/septic shock, and prolonged ICU stays.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:03.573839+00:00"}
{"study_id": 71571, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-Carnitine supplementation improves liver fat content and cardiometabolic outcomes in overweight/obese women with PCOS.", "results_summary": "The study found no significant beneficial effects of L-Carnitine on liver fat content or cardiometabolic markers (LAP, AIP, AC, Castelli II index) compared to placebo after 12 weeks.", "population_specificity": "Overweight/obese women with polycystic ovary syndrome (PCOS).", "effective_dosage": "1000 mg/d (capsule form).", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:03.833322+00:00"}
{"study_id": 71570, "supplement_id": 1266, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine whether propionyl-L-carnitine (PLC) is effective compared to placebo or other interventions in improving pain-free and maximum walking distance for people with intermittent claudication (Fontaine stage II).", "results_summary": "PLC showed mild to moderate improvement in walking distance (26% relative improvement in maximal walking performance and 31% in pain-free walking distance) compared to placebo, with similar safety profiles. No significant differences in adverse events were noted between PLC and placebo.", "population_specificity": "People with stable intermittent claudication (Fontaine stage II).", "effective_dosage": "1-2 grams per day, orally (9 studies) or intravenously (3 studies).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:04.571843+00:00"}
{"study_id": 71574, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness and evidence for L-Carnitine as a treatment for symptoms caused by central disorders of hypersomnolence.", "results_summary": "The study included L-Carnitine among the interventions reviewed but did not provide detailed findings specific to its efficacy or safety in the abstract. The task force summarized the evidence, but the abstract lacks specific results for L-Carnitine.", "population_specificity": "Adults and children with central disorders of hypersomnolence.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:06.498113+00:00"}
{"study_id": 71575, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine the effects of L-carnitine supplementation on inflammatory markers, blood sugar control, and quality of life in children on hemodialysis.", "results_summary": "L-carnitine significantly reduced IL-6 and fasting blood sugar levels, increased free carnitine and quality of life scores, but did not significantly affect high-sensitivity C-reactive protein or albumin levels.", "population_specificity": "Children aged 6-18 years on hemodialysis.", "effective_dosage": "50 mg/kg of L-carnitine.", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:07.943798+00:00"}
{"study_id": 71572, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the synergistic effects of low-dose L-carnitine tartrate and creatine monohydrate on muscle protein synthesis and anabolic pathway activation in human myoblasts, as well as the impact of LMP formulation on creatine bioavailability.", "results_summary": "The combination of L-carnitine tartrate and creatine monohydrate significantly increased protein synthesis and activated anabolic signaling (AKT and RPS6 phosphorylation) in human myoblasts. LMP formulation improved creatine bioavailability in rodents and humans, with dose-dependent increases in plasma creatine and serum L-carnitine levels.", "population_specificity": "Primary human myoblasts, Wistar rats, and healthy human subjects.", "effective_dosage": "50 \u00b5M L-carnitine tartrate and 5 \u00b5M creatine monohydrate (in vitro); 500 mg L-carnitine (from L-carnitine tartrate) with 100, 200, or 500 mg LMP-formulated creatine (in humans).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:08.065128+00:00"}
{"study_id": 71576, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of L-Carnitine supplementation on insulin resistance, SHBG, and lipid profile in overweight/obese women with PCOS.", "results_summary": "L-Carnitine supplementation significantly improved insulin resistance markers but had no significant effect on SHBG or lipid profile. The study suggests potential benefits for insulin sensitivity in this population.", "population_specificity": "Overweight/obese women with polycystic ovary syndrome (PCOS).", "effective_dosage": "1000 mg/day", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:09.300875+00:00"}
{"study_id": 71578, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of L-Carnitine deficiency in drug-resistant epilepsy and its potential correction through coadministration with valproic acid.", "results_summary": "The study suggests that L-Carnitine deficiency, whether intrinsic or induced by valproic acid, may contribute to drug-resistant epilepsy, and its coadministration with valproic acid could help mitigate this issue.", "population_specificity": "Patients with drug-resistant epilepsy, particularly those on valproic acid therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Valproic acid (depletes L-Carnitine levels)", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:10.896405+00:00"}
{"study_id": 71579, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the evidence for L-Carnitine as a treatment for depression, particularly its efficacy compared to other integrative therapies.", "results_summary": "The study found that L-Carnitine has a moderate level of evidence in treating depression, though it was not among the highest-evidence supplements like St. John's Wort or Omega-3 Fatty Acids.", "population_specificity": "Patients with depression (specific subgroup not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:11.013607+00:00"}
{"study_id": 71580, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were not studying L-Carnitine; the abstract focuses on novel peritoneal dialysis solutions and their effects on fibrosis and metabolic outcomes.", "results_summary": "The abstract does not mention L-Carnitine or its effects.", "population_specificity": "Patients with end-stage kidney disease undergoing peritoneal dialysis.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:11.071328+00:00"}
{"study_id": 71577, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of L-Carnitine in treating valproic acid (VPA) toxicity, comparing it with alternative treatments like carbapenem antibiotics.", "results_summary": "The abstract mentions L-Carnitine as part of traditional treatment for VPA toxicity but focuses more on the effectiveness of meropenem in lowering toxic VPA levels. No specific outcomes for L-Carnitine are detailed.", "population_specificity": "A 38-year-old female with epilepsy and VPA toxicity, along with a review of four other VPA poisoning cases.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:11.206751+00:00"}
{"study_id": 71581, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential role of L-Carnitine as a caloric restriction-related nutrient in improving cardiometabolic health in individuals with type 2 diabetes and cardiovascular disease.", "results_summary": "The abstract suggests L-Carnitine may activate AMPK/SIRT1 signaling, similar to caloric restriction, but does not provide specific efficacy data. The study also discusses limitations related to its use in managing T2DM and CVD.", "population_specificity": "Individuals with type 2 diabetes and cardiovascular disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:13.963557+00:00"}
{"study_id": 71583, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate the immunomodulatory effect of L-carnitine on immune cells in chronic HBV infection.", "results_summary": "The study measured plasma L-Cn levels and conducted RNA sequencing to analyze transcriptional profiles of immune cells after L-Cn stimulation, suggesting potential immunomodulatory effects in chronic HBV infection.", "population_specificity": "Treatment-na\u00efve chronic HBV patients (n=141), patients with HBsAg loss post-antiviral treatment (n=38), and HBV-related HCC patients (n=47).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:15.647260+00:00"}
{"study_id": 71582, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess whether adding L-Carnitine to rifaximin treatment could further reduce the recurrence of hepatic encephalopathy (HE) and improve outcomes.", "results_summary": "The study found that adding L-Carnitine to rifaximin significantly reduced hospitalization rates (9.8% vs. 30.9%) but did not show a statistically significant additional reduction in the PSE index compared to rifaximin alone.", "population_specificity": "Patients with hepatic encephalopathy receiving rifaximin.", "effective_dosage": "1,500 mg/day of L-Carnitine.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:15.706955+00:00"}
{"study_id": 71584, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 50, "study_goal": "The researchers aimed to analyze the clinical presentation, genetic mutations, and treatment outcomes (including L-Carnitine use) in Chinese patients with Maple Syrup Urine Disease (MSUD).", "results_summary": "L-Carnitine was part of a protein-restricted diet treatment in 96.2% of cases, but the study did not isolate its specific effects. Outcomes included 40.4% improvement and 36.5% mortality, though causality with L-Carnitine was not assessed.", "population_specificity": "Newborns and infants with MSUD in China.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:17.902229+00:00"}
{"study_id": 71587, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether reducing L-Carnitine supplementation affects carnitine kinetics and cardiac function in hemodialysis patients previously treated with LC.", "results_summary": "Reducing LC administration to once weekly significantly decreased plasma carnitine fractions and RBC-free carnitine levels, with further decreases in the placebo group. Cardiac function was evaluated using echocardiography and BNP levels, though specific outcomes are not detailed in the abstract.", "population_specificity": "Hemodialysis patients previously treated with intravenous LC.", "effective_dosage": "1000 mg per HD session (three times weekly initially, then adjusted to once weekly or placebo).", "study_duration": "Six months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:20.008155+00:00"}
{"study_id": 71586, "supplement_id": 1266, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether daily L-carnitine supplementation is safe, feasible, and effective in improving muscle strength and reducing fatigue in children with neurofibromatosis type 1 (NF1).", "results_summary": "The study found that L-carnitine supplementation was safe with no adverse events, significantly improved muscle strength (53-66% increase) and performance (10% increase in long jump and 6MWT distance), and had high compliance (95%). Parent reports indicated no negative impact on quality of life.", "population_specificity": "Children aged 8-12 years with NF1, muscle weakness, and fatigue, na\u00efve to L-carnitine.", "effective_dosage": "1000 mg daily oral levocarnitine tartrate.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:20.694108+00:00"}
{"study_id": 71589, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of L-carnitine supplementation on serum lipid profiles, apolipoproteins, and free carnitine levels in children with chronic kidney disease on hemodialysis.", "results_summary": "L-carnitine supplementation significantly reduced LDL-C and total cholesterol levels and increased free carnitine levels, but did not significantly affect ApoB levels, ApoB/ApoA1 ratio, TG, or HDL-C compared to placebo.", "population_specificity": "Children aged 6-18 years with chronic kidney disease on hemodialysis.", "effective_dosage": "50 mg/kg/day", "study_duration": "10 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:20.857177+00:00"}
{"study_id": 71588, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to compare the effects of adding acetyl-L-carnitine (ALC) to metformin plus pioglitazone versus metformin plus pioglitazone alone on endocrine, metabolic, and stress parameters in women with PCOS.", "results_summary": "The combo group (ALC + metformin + pioglitazone) showed significant improvements in insulin resistance, adiponectin levels, testosterone, LH, body circumference, and perceived stress scores compared to the metformin plus pioglitazone group. Notably, 97.2% of the combo group achieved regular menstrual cycles versus only 12.9% in the other group.", "population_specificity": "147 women with polycystic ovary syndrome (PCOS).", "effective_dosage": "1500 mg acetyl-L-carnitine (ALC) twice daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:22.451538+00:00"}
{"study_id": 71590, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the literature on VPA-induced encephalopathy, including its association with L-carnitine deficiency.", "results_summary": "The abstract indicates that VPA-induced encephalopathy is linked to L-carnitine deficiency, but it does not provide specific findings on L-carnitine's effects or outcomes.", "population_specificity": "Patients with VPA-induced encephalopathy (no specific demographic details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:23.671471+00:00"}
{"study_id": 71592, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether long-term L-Carnitine treatment alleviates white-matter microstructural damage and cognitive decline in hemodialysis patients.", "results_summary": "Long-term L-Carnitine treatment was associated with reduced white-matter microstructural damage, lower inflammation markers, improved cognitive test performance, and higher carnitine levels compared to short-term or no treatment.", "population_specificity": "Hemodialysis patients (14 participants, split into two groups) and 10 age- and sex-matched controls.", "effective_dosage": "Not specified", "study_duration": "Long-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:24.679392+00:00"}
{"study_id": 71591, "supplement_id": 1266, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to assess the effect of L-Carnitine supplementation on nonalcoholic fatty liver disease (NAFLD) in children and adolescents.", "results_summary": "The study found no significant differences in liver enzyme levels or sonographic grades of fatty liver between the L-Carnitine and placebo groups, indicating L-Carnitine did not improve biochemical or sonographic markers of NAFLD. Within-group analysis showed significant changes in liver enzymes for both groups, likely due to lifestyle changes.", "population_specificity": "Children and adolescents aged 5-15 years with NAFLD.", "effective_dosage": "50 mg/kg/day, divided into two doses.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:25.098328+00:00"}
{"study_id": 71593, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of L-carnitine/L-acetyl-carnitine (LC/LAC) and N-acetyl-cysteine (NAC) in improving sperm motility in men with idiopathic asthenozoospermia.", "results_summary": "The meta-analysis found that LC/LAC and NAC significantly improved sperm motility in men with idiopathic asthenozoospermia, based on data from seven studies involving 621 patients.", "population_specificity": "Men with idiopathic asthenozoospermia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:26.490534+00:00"}
{"study_id": 71596, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "To review L-carnitine's role in migraine treatment and present a case of a patient with chronic migraine responsive to L-carnitine supplementation.", "results_summary": "The study found that L-carnitine supplementation improved chronic migraine symptoms in a patient with carnitine deficiency, suggesting a potential dose-dependent response. It also proposed that L-carnitine with other mitochondrial cofactors may serve as a migraine preventive.", "population_specificity": "Patient with chronic migraine-like headaches and carnitine deficiency.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:30.026506+00:00"}
{"study_id": 71597, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effectiveness of L-carnitine in treating renal anemia in hemodialysis patients, specifically its impact on plasma L-carnitine levels, erythropoietin responsiveness, and required ESA doses.", "results_summary": "L-carnitine significantly increased plasma L-carnitine levels, improved ESA response, and reduced required ESA doses, but did not significantly raise hemoglobin or hematocrit levels. The effects were consistent regardless of treatment duration or administration route.", "population_specificity": "Hemodialysis patients with renal anemia", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:30.315197+00:00"}
{"study_id": 71601, "supplement_id": 1266, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "To assess the efficacy and safety of L-carnitine as a cardioprotective drug in children with type 1 diabetes mellitus, focusing on echocardiographic parameters, lipid profile, and carotid intima-media thickness.", "results_summary": "L-carnitine significantly improved lipid profile (reduced total cholesterol and LDL, increased HDL) and echocardiographic parameters, with no significant change in carotid intima-media thickness. It was safe and well-tolerated.", "population_specificity": "Children with type 1 diabetes mellitus for more than 3 years.", "effective_dosage": "50 mg/kg/day", "study_duration": "4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:34.004107+00:00"}
{"study_id": 71602, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the clinical efficacy of L-carnitine therapy in patients with dilated cardiomyopathy (DCM).", "results_summary": "The meta-analysis found that L-carnitine therapy was associated with significant improvement in overall efficacy for DCM patients, though the evidence was limited by low methodological quality and high clinical heterogeneity among the included studies.", "population_specificity": "1,455 DCM patients in China.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:34.004982+00:00"}
{"study_id": 71600, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to examine existing research on carnitine metabolism in alcohol use disorders (AUDs) and explore carnitine's potential role in AUD pathophysiology and treatment.", "results_summary": "Alcohol use impacts carnitine metabolism, particularly in alcoholic cirrhosis, where carnitine levels are often increased. Limited evidence suggests carnitine supplementation may reduce cravings, anhedonia, withdrawal symptoms, and improve cognition in AUD, but only three placebo-controlled trials were identified.", "population_specificity": "Individuals with alcohol use disorders, particularly those with alcoholic cirrhosis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:35.706884+00:00"}
{"study_id": 71599, "supplement_id": 1266, "safety_score": "85", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of L-carnitine supplementation and a low-calorie diet on improving knee osteoarthritis (KOA) in obese women, and to investigate L-carnitine's impact on KOA improvement in this population.", "results_summary": "L-carnitine supplementation significantly improved BMI and weight compared to placebo but showed no significant effects on other anthropometric measures, body composition, clinical symptoms, or biomarkers like CRP and MDA. Some lipid profile and fat mass improvements were noted within the L-carnitine group compared to baseline, but not versus placebo.", "population_specificity": "Obese women with knee osteoarthritis (n=76).", "effective_dosage": "1000 mg daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:36.551891+00:00"}
{"study_id": 71603, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 70, "study_goal": "The researchers aimed to determine if adding L-Carnitine to gonadotropins improved ART outcomes in frozen-thawed embryo transfer cycles among women with PCOS.", "results_summary": "The study found that oral L-Carnitine administration during ovulation induction did not improve laboratory or pregnancy outcomes in PCOS women, despite comparable stimulation duration and endometrial thickness between groups.", "population_specificity": "Women with PCOS undergoing frozen-thawed embryo transfer cycles.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:37.221842+00:00"}
{"study_id": 71604, "supplement_id": 1266, "safety_score": "80", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of L-Carnitine as a therapy for muscle wasting in cirrhosis by examining its anti-inflammatory, antioxidant, and ammonia-lowering properties.", "results_summary": "The study found that L-Carnitine shows promise for treating muscle loss in cirrhosis due to its multimodal effects, including anti-inflammatory and antioxidant properties, as well as its ability to lower ammonia levels. However, further clinical trials are needed to confirm its efficacy.", "population_specificity": "Patients with cirrhosis experiencing sarcopenia (muscle wasting).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:37.718279+00:00"}
{"study_id": 71595, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 45, "study_goal": "The researchers aimed to assess the effectiveness and safety of L-Carnitine in combination with metformin and clomiphene compared to metformin, clomiphene, and placebo for improving pregnancy outcomes and weight loss in obese women with subfertility.", "results_summary": "The study found uncertain effects of L-Carnitine on miscarriage rates (OR 3.58, 95% CI 0.73\u201317.55) and clinical pregnancy (OR 5.56, 95% CI 2.57\u201312.02), with very low-quality evidence. No significant impact on BMI was observed (MD -0.3, 95% CI -1.17 to 0.57).", "population_specificity": "Obese women with subfertility.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:39.677897+00:00"}
{"study_id": 71594, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to quantitatively evaluate the efficacy of L-carnitine supplementation on glycemic control (FPG and HbA1c) in type 2 diabetes mellitus patients using model-based meta-analysis.", "results_summary": "The study found that L-carnitine supplementation had a significant effect on reducing fasting plasma glucose (FPG) and glycated hemoglobin (HbA1c) in type 2 diabetes patients, providing quantitative efficacy data for glycemic control.", "population_specificity": "Type 2 diabetes mellitus patients", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:40.391551+00:00"}
{"study_id": 71605, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to summarize the design and findings of RCTs in the prevention and management of idiosyncratic drug-induced liver injury (DILI).", "results_summary": "The abstract does not provide specific findings regarding L-Carnitine's effects.", "population_specificity": "Not specified (focus on RCTs in idiosyncratic DILI).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:40.832791+00:00"}
{"study_id": 71606, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the role of L-Carnitine in treating inborn errors of metabolism (IEMs), particularly its potential to aid in acylcarnitine excretion in fatty acid oxidation disorders.", "results_summary": "The abstract suggests that L-Carnitine can be used as a dietary intervention to remove offending compounds like acylcarnitines in fatty acid oxidation disorders, but it does not provide specific efficacy data. The broader focus is on the gut microbiome's role in IEMs and potential interventions like pre- and probiotics.", "population_specificity": "Patients with inborn errors of metabolism (IEMs), specifically fatty acid oxidation disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:43.173856+00:00"}
{"study_id": 71608, "supplement_id": 1266, "safety_score": "85", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of L-Carnitine supplementation on cardiorespiratory function in hemodialysis patients using ergospirometry parameters.", "results_summary": "The study found no significant differences in most cardiorespiratory factors between the L-Carnitine and placebo groups, except for CRP (higher in placebo) and PET-CO2 (increased in treatment group but decreased in placebo). L-Carnitine may help reduce inflammation and improve life quality in hemodialysis patients.", "population_specificity": "Chronic hemodialysis patients (n=46)", "effective_dosage": "2 g/d orally", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:44.314462+00:00"}
{"study_id": 71609, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the role of organic cation transporters (OCT/Ns) in transporting endogenous compounds like L-Carnitine and their potential implications in lung diseases and drug targeting.", "results_summary": "The abstract highlights that OCT/Ns are involved in transporting L-Carnitine and other compounds, with potential relevance to respiratory disorders and chronic lung diseases, but does not provide specific findings on L-Carnitine's effects.", "population_specificity": "Not specified (review of transporter physiology and pharmacology).", "effective_dosage": "Not available", "study_duration": "Not applicable (review article).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:45.746305+00:00"}
{"study_id": 71611, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-carnitine supplementation improved muscle spasm, cardiac function, and renal anemia in dialysis patients.", "results_summary": "L-carnitine supplementation increased serum carnitine levels but did not significantly improve muscle spasms, though 31% of long-term HD patients reported reduced cramping. Hemoglobin levels significantly improved in the HD group at 12 and 24 months.", "population_specificity": "80 Japanese dialysis patients (62 hemodialysis, 18 peritoneal dialysis).", "effective_dosage": "Oral L-carnitine (600 mg/day) for all patients; HD patients also received intravenous L-carnitine (1000 mg three times/week).", "study_duration": "12 months for oral supplementation; HD patients received an additional 12 months of intravenous treatment (total 24 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:46.499187+00:00"}
{"study_id": 71612, "supplement_id": 1266, "safety_score": "30", "efficacy_score": 40, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of L-carnitine in the context of mitochondrial disease management, based on emerging clinical data.", "results_summary": "The study found that L-carnitine may accelerate atherosclerotic disease, suggesting potential safety concerns, but did not provide strong evidence for its efficacy in mitochondrial disease.", "population_specificity": "Individuals with primary mitochondrial disease, including those with MELAS syndrome and Leigh syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:46.744262+00:00"}
{"study_id": 71613, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 55, "quality_score": 65, "study_goal": "To identify the role of L-carnitine in the treatment of varicocele, either as a primary or adjuvant therapy.", "results_summary": "The evidence on L-carnitine's role in varicocele treatment is sparse and inconclusive. Some studies suggest modest benefits in low-grade or subclinical varicocele, while surgery appears superior overall.", "population_specificity": "Infertile men with varicocele.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:48.202396+00:00"}
{"study_id": 71614, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of L-Carnitine as part of the treatment for glutaric aciduria type I (GA1) to prevent brain injury during intercurrent illnesses.", "results_summary": "The study found that L-Carnitine, when administered alongside a low-lysine diet and emergency measures, contributes to a favorable long-term neurocognitive outcome in early-treated GA1 patients. However, late-treated or untreated patients may still experience severe irreversible neurocognitive disabilities.", "population_specificity": "Patients with glutaric aciduria type I (GA1), particularly infants and young children.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:49.691454+00:00"}
{"study_id": 71615, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine whether acute L-carnitine infusion could alleviate lipid-induced insulin resistance and metabolic inflexibility in healthy volunteers.", "results_summary": "L-carnitine infusion increased plasma carnitine availability but did not improve peripheral insulin sensitivity or metabolic flexibility during lipid-induced insulin resistance. No changes in skeletal muscle carnitine availability were observed.", "population_specificity": "Eight young, healthy volunteers.", "effective_dosage": "28 mg/kg (intravenous infusion).", "study_duration": "Acute (single infusion during hyperinsulinemic-euglycemic clamp).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:50.498350+00:00"}
{"study_id": 71617, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential role of mitochondrial dysfunction in autism spectrum disorder (ASD) and assess treatments like L-Carnitine that target mitochondrial function.", "results_summary": "The study suggests that L-Carnitine, among other mitochondrial-targeting treatments, may be useful for improving function in children with ASD, particularly those with mitochondrial abnormalities. It highlights that mitochondrial dysfunction could affect up to 80% of children with ASD, and L-Carnitine shows promise as a therapeutic option.", "population_specificity": "Children with autism spectrum disorder (ASD), particularly those with mitochondrial dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:52.227002+00:00"}
{"study_id": 71618, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of L-Carnitine supplementation versus exercise on muscle status and physical activity in hemodialysis patients.", "results_summary": "L-Carnitine significantly increased muscle mass, reduced fat mass, improved physical function (e.g., shorter chair stand-up time and 10-m walk test), and enhanced thigh circumference compared to the exercise group. Baseline fibroblast growth factor-21 and myostatin levels predicted the improvements in exercise activities.", "population_specificity": "Hemodialysis patients", "effective_dosage": "Not specified", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:53.388823+00:00"}
{"study_id": 71620, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of L-carnitine supplementation on 28-day and one-year mortality in septic patients.", "results_summary": "L-carnitine supplementation reduced one-year mortality in septic patients with SOFA > 12 but had no significant effect on 28-day mortality. The study concluded that L-carnitine may not have a clinically significant effect on mortality overall.", "population_specificity": "Septic patients, particularly those with SOFA scores > 12.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:54.489613+00:00"}
{"study_id": 71621, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the efficacy of L-Carnitine in treating NAFLD/NASH based on clinical trials that included liver biopsy assessment.", "results_summary": "The study identified L-Carnitine as one of the agents tested in a single clinical trial, but no specific efficacy or safety results were detailed in the abstract.", "population_specificity": "Patients with NAFLD/NASH.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:54.659622+00:00"}
{"study_id": 71619, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if L-Carnitine and other biomarkers could predict relapse in patients with quiescent inflammatory bowel disease (IBD).", "results_summary": "Propionyl-L-carnitine and carnitine were among the metabolomic markers associated with relapse in multivariable models, suggesting their potential role in predicting disease recurrence. The combined proteomic and metabolomic risk scores showed strong predictive ability for relapse (AUC 0.83).", "population_specificity": "Patients with quiescent Crohn disease (n=108) and ulcerative colitis (n=56).", "effective_dosage": "Not specified", "study_duration": "Median follow-up of 1 year", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:55.052205+00:00"}
{"study_id": 71622, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "To evaluate the effectiveness of acetyl-L-carnitine in preventing chemotherapy-induced peripheral neuropathy (CIPN) in adult cancer survivors.", "results_summary": "The study found that acetyl-L-carnitine should be discouraged for preventing CIPN, as no agents were recommended for prevention. Duloxetine was the only treatment with evidence for managing painful CIPN, though benefits were limited.", "population_specificity": "Adult cancer survivors undergoing chemotherapy.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:57.147255+00:00"}
{"study_id": 71623, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to visualize spatially resolved reprogramming of carnitine metabolism in heterogeneous breast cancer using mass spectrometry imaging (MSI).", "results_summary": "The study proposed an MSI-based metabolomic strategy to analyze carnitine metabolism in breast cancer but did not report specific findings on L-Carnitine's effects.", "population_specificity": "Heterogeneous breast cancer (no further details provided).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:58.401983+00:00"}
{"study_id": 71625, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of L-carnitine on echocardiographic changes in \u03b2-thalassemia major and intermedia patients.", "results_summary": "L-carnitine reduced left ventricular dilatation, left ventricular hypertrophy, and systolic blood pressure while increasing cardiac output significantly compared to controls.", "population_specificity": "\u03b2-thalassemia major and intermedia patients in Iran.", "effective_dosage": "Not specified", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:19:59.489920+00:00"}
{"study_id": 71626, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the efficacy of levocarnitine in improving malnutrition biomarkers in maintenance hemodialysis (MHD) patients.", "results_summary": "The meta-analysis found that L-carnitine significantly improved albumin, total protein, transferrin, and prealbumin levels in MHD patients, with statistically significant results (P<0.001). No publication bias was detected.", "population_specificity": "Maintenance hemodialysis (MHD) patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:01.471656+00:00"}
{"study_id": 71627, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine the role of glutathione (GSH) levels and antioxidant function in the brain in relation to anxiety and stress-related psychopathologies, and identify compounds that could raise GSH levels.", "results_summary": "The abstract does not specifically mention L-Carnitine but discusses promising compounds that could raise GSH levels in the brain by increasing precursor availability or activating Nrf2, with a high tolerability and safety profile.", "population_specificity": "Not specified (general focus on stress-related psychopathologies)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:02.042522+00:00"}
{"study_id": 71607, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and efficacy of carnitine supplementation for idiopathic male infertility, focusing on sperm parameters and clinical pregnancy rates.", "results_summary": "Carnitines significantly improved total sperm motility, progressive sperm motility, and sperm morphology but had no effect on sperm concentration or clinical pregnancy rates. The evidence was limited by the small number of studies and patient numbers.", "population_specificity": "Men with idiopathic infertility.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:02.554816+00:00"}
{"study_id": 71630, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the role of acetyl-L-carnitine (ALC) in dementia, focusing on its mechanisms of action and clinical implications.", "results_summary": "The study found mixed evidence for ALC's efficacy in dementia, with some studies showing benefits in cognitive decline and psychometric tests, while others concluded insufficient evidence for clinical use. Potential mechanisms include neuroprotection, mitochondrial support, and liver detoxification enhancement.", "population_specificity": "Patients with primary and secondary dementia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:03.099135+00:00"}
{"study_id": 71631, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to examine the effect of L-carnitine supplementation on body weight and composition by analyzing the maximum number of randomized controlled trials (RCTs) and conducting a dose-response analysis.", "results_summary": "The meta-analysis found that L-carnitine supplementation significantly reduced body weight, BMI, and fat mass, particularly in adults with overweight/obesity, though the effects were modest.", "population_specificity": "Adults, particularly those with overweight/obesity (2292 participants across 37 RCTs).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:05.009810+00:00"}
{"study_id": 71632, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to investigate the acute metabolic effects of low dosages of L-carnitine under fat-mobilizing conditions, including its interaction with carbohydrates.", "results_summary": "The study examined metabolic responses to L-carnitine supplementation under fasting and exercise conditions, comparing different dosages and combinations (e.g., with carbohydrates). Specific metabolic outcomes were not detailed in the abstract.", "population_specificity": "Healthy subjects (Study 1: n=5; Study 2: n=6)", "effective_dosage": "Study 1: 750 mg L-carnitine (LC), 750 mg LC + 50 g CHO; Study 2: 500 mg LC, 30 mg CoQ", "study_duration": "Acute intervention (single dose followed by 30 min exercise and 3.5-h recovery)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:07.494320+00:00"}
{"study_id": 71633, "supplement_id": 1266, "safety_score": "95", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether a multi-nutrient supplement containing L-Carnitine could improve sperm parameters and pregnancy rates in men with idiopathic male infertility.", "results_summary": "The study found that the supplement significantly improved sperm quality (69.0% normal spermiograms vs. 22.0% in placebo) and increased pregnancy rates (23.8% vs. 4.9%) after 4 months, with no reported adverse events.", "population_specificity": "Males aged 21-50 with idiopathic male infertility and abnormal sperm parameters (oligo-, astheno-, or teratozoospermia).", "effective_dosage": "Not specified in the abstract.", "study_duration": "4 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:08.452603+00:00"}
{"study_id": 71636, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to highlight emerging therapies, including L-Carnitine, for treating hepatic encephalopathy and mitigating cognitive impairment.", "results_summary": "The abstract does not provide specific findings about L-Carnitine's effects.", "population_specificity": "Patients with hepatic encephalopathy due to advanced liver disease.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.341951+00:00"}
{"study_id": 71635, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to examine the effect of acupuncture on obesity-related parameters, including serum metabolic profiles such as carnitine levels.", "results_summary": "The study found that acupuncture significantly increased certain carnitine levels (C2, C4, C6, and L-carnitine) in obese participants, though other metabolic and anthropometric parameters showed no significant differences between groups. The increased carnitine levels suggest potential long-term benefits for obese individuals.", "population_specificity": "120 obese participants", "effective_dosage": "Not specified", "study_duration": "6 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:09.924846+00:00"}
{"study_id": 71634, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine if the inclusion of acetyl-l-carnitine (ALC) alongside other antioxidants improves human embryo development and pregnancy potential during IVF.", "results_summary": "The study found that the A3 group (including ALC) significantly improved embryo quality, implantation rates, and ongoing pregnancy rates, particularly in patients aged 35-40 years, compared to the control group.", "population_specificity": "133 IVF patients (specifically highlighting improved outcomes in those aged 35-40 years).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:10.051886+00:00"}
{"study_id": 71637, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review various therapies, including L-Carnitine, for the pharmacologic management of hepatic encephalopathy.", "results_summary": "The abstract does not provide specific findings about L-Carnitine's effects, only mentioning it as one of several therapies under review.", "population_specificity": "Patients with hepatic encephalopathy (not further specified).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:11.053979+00:00"}
{"study_id": 71629, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to assess the effects of dietary interventions, including L-Carnitine, on MS-related outcomes compared to placebo or other interventions.", "results_summary": "The abstract does not provide specific results for L-Carnitine, only mentioning it as one of several dietary supplements examined in a subset of trials. No distinct findings or conclusions were reported for L-Carnitine.", "population_specificity": "Adults with MS, defined by established criteria, presenting to MS clinics in Europe, North America, and the Middle East.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:13.180313+00:00"}
{"study_id": 71639, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the effects of L-Carnitine supplementation on exercise-induced muscle damage through a meta-analysis of randomized controlled trials.", "results_summary": "L-Carnitine significantly improved muscle soreness at multiple follow-up time points and reduced markers of muscle damage (CK, Mb, LDH) at 24 hours, but effects were not observed beyond this period. The supplement was most effective in resistance training groups and untrained populations.", "population_specificity": "Resistance training groups and untrained individuals.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:15.667532+00:00"}
{"study_id": 71642, "supplement_id": 1266, "safety_score": "20", "efficacy_score": 10, "quality_score": 75, "study_goal": "The researchers aimed to assess the effectiveness and safety of acetyl-L-carnitine (ALCAR) in preventing or treating chemotherapy-induced peripheral neuropathy (CIPN).", "results_summary": "The study found that ALCAR was not effective in treating CIPN and actually increased symptom severity. No benefits were observed, and safety concerns were noted.", "population_specificity": "Cancer patients experiencing chemotherapy-induced peripheral neuropathy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:17.431511+00:00"}
{"study_id": 71640, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify metabolic pathways affected by dapagliflozin, including L-carnitine biosynthesis, to understand its renal protective effects.", "results_summary": "The study found that dapagliflozin impacted L-carnitine biosynthesis, linking it to energy metabolism pathways associated with improved renal function in diabetic kidney disease.", "population_specificity": "Patients with type 2 diabetes and non-alcoholic fatty liver disease (n=19 for dapagliflozin, n=6 for placebo), and patients with diabetic kidney disease (n=17) vs. healthy controls (n=30).", "effective_dosage": "Not specified for L-carnitine (dapagliflozin dosage was 10 mg/day).", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:18.406213+00:00"}
{"study_id": 71643, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether the combination of valproic acid and acetyl-L-carnitine (ALC) had a clinically important effect on motor function in SMA types II or III.", "results_summary": "The study found that the combination therapy of valproic acid and ALC had no clinically important effect on motor function scores in SMA types II or III compared to placebo, with a mean difference of 0.64 on the Modified Hammersmith Functional Motor Scale (scale 0 to 40).", "population_specificity": "Children with SMA types II or III confirmed by genetic analysis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:19.114062+00:00"}
{"study_id": 71644, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to provide an overview of human organic cation transporters (OCTs), including their role in modulating the distribution of endogenous compounds like L-Carnitine.", "results_summary": "The study found that OCTs, including OCTN2, are involved in the transport of L-Carnitine and other endogenous compounds, impacting energy metabolism and pharmacokinetics. It also highlighted complex drug-drug interactions at OCTs, such as allosteric inhibition and substrate-dependent inhibitor efficacies.", "population_specificity": "Not specified (focus on in vitro and preclinical data)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Complex drug-drug interactions at OCTs were noted, including allosteric inhibition and substrate-dependent effects.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:19.255385+00:00"}
{"study_id": 71641, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to determine whether an antioxidant formulation containing L-Carnitine improved male fertility outcomes, including semen parameters, DNA fragmentation, and live birth rates.", "results_summary": "The study found no statistically significant improvements in sperm morphology, motility, or DNA fragmentation with the antioxidant treatment, nor did it increase live birth rates compared to placebo.", "population_specificity": "Men with male factor infertility (sperm concentration \u226415 million/mL, motility \u226440%, normal morphology \u22644%, or DNA fragmentation >25%) and their ovulatory female partners (\u226440 years old, with tubal patency).", "effective_dosage": "1,000 mg of L-Carnitine daily (as part of a combined antioxidant formulation).", "study_duration": "3 to 6 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:19.410816+00:00"}
{"study_id": 71645, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the effects of L-Carnitine on SFRP5, omentin, visfatin, and glycemic indices in pemphigus vulgaris patients undergoing corticosteroid treatment.", "results_summary": "L-Carnitine supplementation significantly decreased visfatin levels and increased SFRP5 and omentin levels but had no significant effect on glycemic indices.", "population_specificity": "52 patients with pemphigus vulgaris under corticosteroid treatment.", "effective_dosage": "2 g of L-Carnitine daily.", "study_duration": "8 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:20.765239+00:00"}
{"study_id": 71638, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of zinc(II) complexes, including those with L-Carnitine, as anti-diabetic agents, focusing on their insulin mimetic and glycemic control properties.", "results_summary": "The study found that zinc(II) complexes with L-Carnitine showed promising insulin mimetic and glycemic control properties but remain understudied and lack clinical validation despite minimal safety concerns and health benefits.", "population_specificity": "Not specified (general focus on anti-diabetic potential)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:22.943383+00:00"}
{"study_id": 71646, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 40, "study_goal": "The researchers aimed to determine whether L-Carnitine could effectively treat valproate-induced hyperammonaemic encephalopathy.", "results_summary": "The study found that L-Carnitine infusion led to full recovery in a patient with valproate-induced hyperammonaemic encephalopathy, supporting its efficacy in nonhepatic hyperammonaemia treatment. However, no randomized controlled trials have confirmed this effect.", "population_specificity": "A 44-year-old female with cerebral palsy, epilepsy, and learning disabilities.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:23.699868+00:00"}
{"study_id": 71648, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the level of evidence supporting L-Carnitine's efficacy in improving male fertility based on randomized controlled trials.", "results_summary": "L-Carnitine was identified as one of the five ingredients with the most evidence supporting its positive effect on semen parameters. The study found that only 17% of ingredients in male fertility supplements had published data showing a positive effect, with L-Carnitine being among them.", "population_specificity": "Male fertility supplement users (specific demographic details not provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:25.895020+00:00"}
{"study_id": 71647, "supplement_id": 1266, "safety_score": "75", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the clinical effects of carnitine administration in autism spectrum disorders (ASD), both in non-syndromic forms and ASD associated with genetic disorders.", "results_summary": "Carnitine administration showed potential benefits for treating symptoms in non-syndromic ASD, with some evidence from randomized and open-label trials. Effects in ASD associated with genetic disorders were inconclusive due to limited trials, but improvements in comorbid conditions like intellectual disability and muscular strength were noted.", "population_specificity": "Patients with autism spectrum disorders (ASD), including non-syndromic forms and those associated with genetic disorders.", "effective_dosage": "50-100 mg/kg/day (well tolerated), up to 200 mg/kg/day (with side effects).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:26.286380+00:00"}
{"study_id": 71649, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effect of L-Carnitine supplementation on obesity-related indices through a meta-analysis of randomized controlled trials.", "results_summary": "The meta-analysis of 43 RCTs found that L-Carnitine supplementation significantly reduced weight (WMD: -1.129 kg), though clinical findings were noted as contradictory despite preclinical efficacy.", "population_specificity": "Not specified (general population from included RCTs)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:26.399520+00:00"}
{"study_id": 71651, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether L-Carnitine supplementation improves metabolic flexibility and insulin sensitivity in individuals with impaired glucose tolerance (IGT).", "results_summary": "L-Carnitine supplementation restored metabolic flexibility in IGT subjects to levels comparable to normal glucose tolerance controls, enhanced acetylcarnitine formation, and improved fat oxidation in muscle, but did not affect whole-body insulin sensitivity.", "population_specificity": "Individuals with impaired glucose tolerance (IGT).", "effective_dosage": "2 g/day", "study_duration": "36 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:27.040397+00:00"}
{"study_id": 71650, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effects of L-Carnitine (LC) and L-Acetyl Carnitine (LAC) on semen parameters in men with idiopathic oligoasthenoteratozoospermia (iOAT).", "results_summary": "The study found that LC and LAC significantly improved forward sperm motility, total motile spermatozoa, forward motile spermatozoa, and pregnancy rates, but no significant differences were observed in other semen parameters.", "population_specificity": "Men with idiopathic oligoasthenoteratozoospermia (iOAT).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:27.101351+00:00"}
{"study_id": 71653, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of L-carnitine on relieving imatinib-related muscle cramps in patients with gastrointestinal stromal tumor (GIST).", "results_summary": "L-carnitine significantly reduced cramp severity, frequency, and duration, with 83.3% of patients experiencing improvement and 19.0% achieving complete symptom relief. Quality-of-life measures also showed substantial improvement across all assessed categories.", "population_specificity": "Patients with GIST (median age 60, 52.4% male) experiencing muscle cramps (NRS \u2265 4) while taking imatinib.", "effective_dosage": "500-mg tablet, 2-3 times daily", "study_duration": "Median response time was 10 days (range: 2-30 days)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:32.098561+00:00"}
{"study_id": 71654, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether combining PDT with a topical cream containing L-Carnitine, licochalcone A, and decanediol was more effective in treating acne than PDT alone.", "results_summary": "The active formulation group showed faster and significantly greater reductions in inflammatory and non-inflammatory acne lesions compared to the vehicle group, along with improvements in post-inflammatory hyperpigmentation. The combination treatment was deemed safe and effective for moderate to severe acne.", "population_specificity": "29 volunteers (26 women, 3 men) aged 21-39 with mild to severe facial acne.", "effective_dosage": "Twice daily application of the active formulation cream (specific L-Carnitine dosage not specified).", "study_duration": "10 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:33.174223+00:00"}
{"study_id": 71655, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to assess the efficacy of L-Carnitine supplementation on improving lipid profiles, particularly in relation to dyslipidemia.", "results_summary": "The meta-analysis of 55 RCTs found that L-Carnitine supplementation significantly reduced total cholesterol and triglycerides, with doses above 2 g/day showing favorable effects, though outcomes varied based on participant health and administration route.", "population_specificity": "Patients with dyslipidemia or related conditions (specific health statuses not detailed).", "effective_dosage": "Above 2 g/day (exact frequency not specified).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:33.580806+00:00"}
{"study_id": 71659, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 70, "study_goal": "The researchers aimed to review the potential of metabolic cofactors, including L-Carnitine, to address metabolic imbalances in NAFLD.", "results_summary": "The abstract does not provide specific findings on L-Carnitine's effects, only mentioning its inclusion in a review of metabolic cofactors for NAFLD.", "population_specificity": "Patients with non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:33.658673+00:00"}
{"study_id": 71656, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of L-carnitine supplementation on serum lipid levels in both patients and healthy individuals through a meta-analysis of randomized controlled trials.", "results_summary": "L-carnitine significantly reduced triglycerides, total cholesterol, and LDL-cholesterol levels while increasing HDL-cholesterol, but had no effect on VLDL-cholesterol. Subgroup analyses did not confirm these effects across variables like dosage, age, or health conditions.", "population_specificity": "Patients and healthy individuals from various RCTs.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:33.957603+00:00"}
{"study_id": 71657, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine the effect of L-carnitine supplementation on serum levels of liver enzymes (ALT, AST, GGTP) through a systematic review and meta-analysis of RCTs.", "results_summary": "L-carnitine supplementation significantly reduced serum ALT, AST, and GGTP levels, with greater effects observed at higher doses (\u2265 2000 mg/day), longer durations (> 12 weeks), and in patients with liver diseases. The meta-evidence was graded as \"moderate\" for ALT and AST, and \"low\" for GGTP.", "population_specificity": "1161 participants across 18 RCTs, including patients with liver diseases.", "effective_dosage": "500 to 4000 mg/day", "study_duration": "Varied, with notable effects observed in interventions longer than 12 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:35.243853+00:00"}
{"study_id": 71652, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential role of acetyl-L-carnitine as a complementary therapy for chemotherapy-induced peripheral neuropathy (CIPN).", "results_summary": "The study found less robust evidence for acetyl-L-carnitine in treating CIPN compared to other nutrients like glutamine and omega-3 fatty acids. The effectiveness of acetyl-L-carnitine remains inconclusive due to limited and inconsistent evidence.", "population_specificity": "Patients with chemotherapy-induced peripheral neuropathy (CIPN).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:37.312886+00:00"}
{"study_id": 71660, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the clinical and metabolic effects of L-Carnitine versus N-acetylcysteine in women with clomiphene citrate-resistant PCOS, focusing on pregnancy rates, ovulation, and metabolic improvements.", "results_summary": "L-Carnitine improved lipid profiles significantly and showed comparable pregnancy and ovulation rates to N-acetylcysteine, though N-acetylcysteine was superior in reducing insulin resistance and free testosterone levels.", "population_specificity": "Women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).", "effective_dosage": "Not specified in the abstract.", "study_duration": "3 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:39.671960+00:00"}
{"study_id": 71661, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of L-carnitine supplementation on serum apolipoproteins B100 and AI through a systematic review and meta-analysis of randomized controlled trials.", "results_summary": "The study found that L-carnitine supplementation had no significant effect on Apo B100 or Apo AI concentrations. Factors like BMI, dosage, health condition, and intervention duration could influence outcomes, but overall, the results were inconclusive.", "population_specificity": "Not specified (meta-analysis of 14 trials)", "effective_dosage": "Not specified (varied across included trials)", "study_duration": "Not specified (varied across included trials)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:40.759964+00:00"}
{"study_id": 71664, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the long-term efficacy and safety of carglumic acid combined with standard therapy (including L-Carnitine) versus standard therapy alone in managing hyperammonemia in patients with propionic acidemia (PA) and methylmalonic acidemia (MMA).", "results_summary": "The abstract does not provide specific results regarding L-Carnitine's effects, as the study focuses on carglumic acid's role in combination with standard therapy (which includes L-Carnitine).", "population_specificity": "Patients with PA or MMA, aged \u226415 years.", "effective_dosage": "Not specified for L-Carnitine (only carglumic acid dosage is mentioned: 50 mg/kg/day).", "study_duration": "2-year treatment period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.120436+00:00"}
{"study_id": 71663, "supplement_id": 1266, "safety_score": "75", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to assess the effects of acetyl-L-carnitine (ALC) for the treatment of diabetic peripheral neuropathy (DPN), focusing on pain relief, functional impairment, and safety.", "results_summary": "ALC reduced pain more than placebo at doses greater than 1500 mg/day, but the evidence was of very low certainty. Vibration perception improved after 12 months, but functional and sensory impairment data were lacking or uncertain. Adverse events were reported but did not significantly differ between ALC and placebo or methylcobalamin.", "population_specificity": "People with type 1 or type 2 diabetes mellitus, of any severity, with painful or painless DPN.", "effective_dosage": "1500 mg/day, 2000 mg/day, or 3000 mg/day.", "study_duration": "6 to 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.383335+00:00"}
{"study_id": 71662, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effect of L-carnitine on biochemical factors (ammonia, bilirubin, albumin, AST, BUN, Cr) in patients with hepatic encephalopathy (HE).", "results_summary": "L-carnitine supplementation significantly reduced blood levels of ammonia, bilirubin, AST, BUN, and Cr, and increased albumin in HE patients. The effects were consistent across different ages, dosages, treatment routes, and symptom grades.", "population_specificity": "Patients with hepatic encephalopathy (HE).", "effective_dosage": "Doses less or higher than 4000 mg/day (specific frequencies not detailed).", "study_duration": "Duration varied (short and long-term supplementation, exact lengths not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.677169+00:00"}
{"study_id": 71665, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the clinical features of muscle cramping in liver cirrhosis patients and assess the therapeutic efficacy of interventions, including L-Carnitine.", "results_summary": "L-Carnitine was the most administered treatment (80.5% of treated patients) and significantly improved muscle cramp frequency, pain severity, sleep disturbance, daily activity, and quality of life (each P < 0.001).", "population_specificity": "Liver cirrhosis outpatients (70.6 \u00b1 10.5 years old; 149 males, 140 females) with muscle cramps.", "effective_dosage": "Not specified", "study_duration": "3-4 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:43.717315+00:00"}
{"study_id": 71666, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of L-Carnitine, alone and combined with acetyl-L-Carnitine, in improving semen parameters and male fertility.", "results_summary": "The meta-analysis found that L-Carnitine (2 g/day) combined with acetyl-L-Carnitine (1 g/day) significantly improved asthenozoospermia (SMD 0.57), suggesting a beneficial effect on sperm motility. The study identified L-Carnitine as one of the promising supplements for treating male infertility.", "population_specificity": "Men with infertility issues, specifically those with asthenozoospermia (reduced sperm motility).", "effective_dosage": "2 g/day L-Carnitine + 1 g/day acetyl-L-Carnitine.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:46.529479+00:00"}
{"study_id": 71668, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review existing literature on L-carnitine's potential to modulate mitochondrial dysfunction, oxidative stress, and apoptosis in various diseases.", "results_summary": "L-carnitine demonstrated protective effects by maintaining mitochondrial function and reducing reactive oxygen species production, suggesting potential clinical applications for related diseases.", "population_specificity": "Not specified (review of existing literature across multiple studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:48.046289+00:00"}
{"study_id": 71667, "supplement_id": 1266, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential benefits and safety of L-carnitine in treating internal diseases, focusing on its antioxidant and antihypoxant properties, as well as its lack of interaction with the P450 CYP 3A4 system.", "results_summary": "The study found that L-carnitine has antioxidant and antihypoxant properties, making it beneficial for cardiologists, nephrologists, neurologists, and gerontologists. It showed no effect on the P450 CYP 3A4 system, reducing the likelihood of drug-drug interactions, and demonstrated an increased safety profile in comorbid patients.", "population_specificity": "Patients with internal diseases, including chronic heart failure, myocardial infarction, and chronic renal failure.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned regarding P450 CYP 3A4 metabolism.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:48.903546+00:00"}
{"study_id": 71671, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to identify metabolic profiles that differentiate responsiveness to L-Carnitine in sepsis patients and assess its potential as a therapeutic for septic shock.", "results_summary": "The study found distinct metabolites differentiating 1-year survivors from nonsurvivors in L-Carnitine-treated sepsis patients, with elevated markers of vascular inflammation in nonsurvivors. These results suggest metabolic profiles may help predict treatment responsiveness.", "population_specificity": "21 male sepsis patients enrolled in a placebo-controlled clinical trial.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:50.998745+00:00"}
{"study_id": 71669, "supplement_id": 1266, "safety_score": "30", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety, efficacy, and quality of L-Carnitine as a dietary ingredient for chronic musculoskeletal pain in Special Operations Forces personnel.", "results_summary": "The study recommended against the use of L-Carnitine, concluding that its risks outweighed potential benefits for chronic musculoskeletal pain. No specific positive effects were noted, and the evidence did not support its efficacy.", "population_specificity": "Special Operations Forces personnel and potentially broader military populations.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:51.086152+00:00"}
{"study_id": 71672, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine the efficacy of L-Carnitine (LC) and conjugated linoleic acid (CLA) supplements on haemoglobin levels and inflammatory markers in CKD patients with different haptoglobin genotypes.", "results_summary": "The study found that LC plus CLA supplementation significantly increased haemoglobin levels in CKD patients with anaemia, but no significant changes were observed in inflammatory markers or other measured parameters.", "population_specificity": "Male chronic kidney disease (CKD) patients with anaemia in Iran.", "effective_dosage": "1 g/day of LC and 2.4 g/day of CLA.", "study_duration": "1 month.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:51.794305+00:00"}
{"study_id": 71670, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine the effect of L-carnitine on inflammatory mediators (CRP, TNF-\u03b1, and IL-6) through a meta-analysis of randomized clinical trials.", "results_summary": "L-carnitine supplementation significantly reduced CRP levels and showed slight but statistically significant decreases in IL-6 and TNF-\u03b1 levels, particularly in studies lasting over 12 weeks.", "population_specificity": "Not specified (meta-analysis of multiple RCTs).", "effective_dosage": "Not specified.", "study_duration": "Varied (noted effectiveness in studies >12 weeks).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:52.388677+00:00"}
{"study_id": 71673, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the effects of a therapeutic formulation (Proxeed Plus) containing L-carnitine and L-acetylcarnitine with micronutrients on sperm parameters in men with idiopathic oligoasthenozoospermia.", "results_summary": "The study found significant improvements in sperm volume, progressive motility, vitality, and reduced DNA fragmentation index after 6 months of treatment. Decreased DNA fragmentation was a strong predictor of improved sperm motility.", "population_specificity": "Males aged 19-44 with idiopathic oligoasthenozoospermia who failed to impregnate their partners for 12 months.", "effective_dosage": "Not specified", "study_duration": "3 and 6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.171807+00:00"}
{"study_id": 71658, "supplement_id": 1266, "safety_score": "90", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the protective effects of L-Carnitine supplementation in pemphigus vulgaris patients undergoing corticosteroid treatment.", "results_summary": "L-Carnitine supplementation significantly increased serum carnitine levels and reduced serum BMP4, OPN, and cystatin C levels, but had no significant effect on blood pressure. No harmful side effects were reported.", "population_specificity": "48 patients with pemphigus vulgaris under corticosteroid treatment.", "effective_dosage": "2 g daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.330943+00:00"}
{"study_id": 71674, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-Carnitine (L-Car) could reduce oxidative DNA damage induced by metabolites associated with Maple Syrup Urine Disease (MSUD).", "results_summary": "L-Car reduced in vitro DNA damage caused by Allo, BCAAs, and BCKAs, and reversed elevated urinary 8-OHdG levels in MSUD patients, demonstrating its protective effect against oxidative DNA damage.", "population_specificity": "Patients with Maple Syrup Urine Disease (MSUD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:55.974365+00:00"}
{"study_id": 71676, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the reproductive and metabolic effects of combining L-carnitine with metformin in clomiphene citrate-resistant obese women with PCOS.", "results_summary": "The study found that L-carnitine plus metformin improved reproductive and metabolic outcomes in clomiphene citrate-resistant obese PCOS women, though specific results were not detailed in the abstract.", "population_specificity": "Obese women with polycystic ovary syndrome (PCOS) who were resistant to clomiphene citrate.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:58.830515+00:00"}
{"study_id": 71677, "supplement_id": 1266, "safety_score": "30", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of high-dose oral L-carnitine in treating carnitine uptake disorder (CUD) and assess the implications of long-term treatment.", "results_summary": "The study found that while high-dose oral L-carnitine is recommended for CUD, compliance is poor long-term, and sudden discontinuation may be dangerous. Additionally, L-carnitine metabolizes to TMAO, a risk factor for atherosclerosis, raising concerns about long-term use in asymptomatic patients.", "population_specificity": "Newborns and mothers identified with carnitine uptake disorder (CUD) in New Zealand.", "effective_dosage": "High-dose oral L-carnitine (specific amount not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:20:59.630516+00:00"}
{"study_id": 71679, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if adding L-Carnitine to glimepiride improves insulin resistance and glycemic control in type 2 diabetic patients who did not achieve their goals with glimepiride alone.", "results_summary": "Adding L-Carnitine to glimepiride significantly improved glycemic markers (FBG, PPBG, HbA1c), insulin resistance (HOMA-IR), inflammatory markers (TNF-\u03b1, visfatin), and lipid profiles, but had no effect on BMI or blood pressure.", "population_specificity": "Type 2 diabetic patients from Tanta University Hospital, Egypt, who failed to achieve glycemic goals on glimepiride monotherapy.", "effective_dosage": "1 g L-Carnitine twice daily + 2 mg glimepiride twice daily.", "study_duration": "6 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:02.296020+00:00"}
{"study_id": 71678, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to investigate potential inhibition of placental carnitine uptake by various antiretroviral drugs and the role of OCTN2 in L-Carnitine transport.", "results_summary": "The study confirmed predominant expression and function of OCTN2 over OCTN1 in L-Carnitine transport and identified seven antiretroviral drugs as inhibitors of this process.", "population_specificity": "The study used choriocarcinoma BeWo cells and human placenta-derived models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Antiretroviral drugs (lamivudine, zidovudine, abacavir, tenofovir disoproxil fumarate, rilpivirine, efavirenz, etravirine, ritonavir, lopinavir, atazanavir, saquinavir, tipranavir, raltegravir, dolutegravir, elvitegravir, maraviroc) were noted as potential inhibitors of placental carnitine uptake.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:02.529409+00:00"}
{"study_id": 71680, "supplement_id": 1266, "safety_score": "30", "efficacy_score": 45, "quality_score": 25, "study_goal": "The researchers aimed to assess the benefits and harms of acetyl-L-carnitine for patients with hepatic encephalopathy, focusing on its potential to reduce ammonia toxicity.", "results_summary": "Acetyl-L-carnitine reduced blood ammonium levels compared to placebo, but effects on quality of life, fatigue, and non-serious adverse events were unclear. The evidence was of very low quality due to high risk of bias, small sample sizes, and poor reporting of harms.", "population_specificity": "Patients with cirrhosis and covert or overt hepatic encephalopathy.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:02.998328+00:00"}
{"study_id": 71681, "supplement_id": 1266, "safety_score": "90", "efficacy_score": 20, "quality_score": 80, "study_goal": "The researchers aimed to determine whether acetyl-L-carnitine could promote nerve regeneration and improve functional recovery in patients with severe carpal tunnel syndrome following surgery.", "results_summary": "The study found that acetyl-L-carnitine was well tolerated but did not significantly improve nerve regeneration or functional outcomes compared to placebo in patients with severe carpal tunnel syndrome. Both groups showed postoperative improvements, but no differences were observed between them.", "population_specificity": "Adults with severe carpal tunnel syndrome (60% women, mean age 59 \u00b1 2 years).", "effective_dosage": "3000 mg/day orally.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:03.226435+00:00"}
{"study_id": 71682, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to review the role of nutritional interventions, including L-Carnitine, in addressing immune dysregulation and nutrient deficiencies in chronic fatigue syndrome (CFS).", "results_summary": "The abstract suggests that L-Carnitine is among the nutrients commonly deficient in CFS patients, but it does not provide specific efficacy data or outcomes related to its supplementation.", "population_specificity": "Chronic fatigue syndrome (CFS) patients with reported nutrient deficiencies.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:03.710757+00:00"}
{"study_id": 71683, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the preventive effect of L-carnitine on renal scarring in children with acute pyelonephritis.", "results_summary": "The study found that L-carnitine significantly reduced renal scarring compared to the control group, with worsening kidney lesions being significantly higher in the control group after 6 months. No significant differences were observed in baseline characteristics or lab data between the two groups.", "population_specificity": "Children aged 6 months to 10 years with acute pyelonephritis.", "effective_dosage": "Not specified in the abstract.", "study_duration": "7 days during the acute phase of infection.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:06.750631+00:00"}
{"study_id": 71684, "supplement_id": 1266, "safety_score": "75", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to determine the effects of L-carnitine supplementation on parameters of chronic kidney disease-mineral bone disorder in hemodialysis patients.", "results_summary": "L-carnitine supplementation increased calcium and phosphate plasma concentrations but showed no detectable effect on parathyroid hormone (PTH) or FGF23 levels. No significant downregulation of PTH or FGF23 was observed.", "population_specificity": "Incident hemodialysis subjects (n=92).", "effective_dosage": "Not specified in the abstract.", "study_duration": "1 year.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:06.893191+00:00"}
{"study_id": 71687, "supplement_id": 1266, "safety_score": "80", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to review available data on the renal safety of L-carnitine in athletes and bodybuilders.", "results_summary": "The study found that L-carnitine up to 6000 mg/day is generally considered safe in healthy adults, but risks and benefits for athletes' and bodybuilders' kidneys have not been evaluated.", "population_specificity": "Athletes and bodybuilders", "effective_dosage": "Up to 6000 mg/day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:10.591520+00:00"}
{"study_id": 71685, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the controversial role of L-Carnitine therapy in treating specific fatty acid oxidation disorders (FAODs), particularly VLCAD, TFP, CPT2, and CACT deficiencies.", "results_summary": "The study found that L-Carnitine supplementation may be accepted for CPT2/CACT and multiple acyl-CoA dehydrogenase deficiencies, but its efficacy for VLCAD/TFP deficiency remains controversial. No clear adverse effects or benefits were highlighted for L-Carnitine in the abstract.", "population_specificity": "Patients with mitochondrial fatty acid oxidation disorders (FAODs), including VLCAD, TFP, CPT2, and CACT deficiencies.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.237877+00:00"}
{"study_id": 71689, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to highlight the potential risks and benefits of antioxidant therapy, including L-Carnitine, in treating conditions like male infertility, emphasizing the need for further research.", "results_summary": "The abstract suggests that antioxidants like L-Carnitine are commonly used to combat oxidative stress but warns of potential toxicity and reductive stress from excessive consumption, noting a lack of clear therapeutic benefits in high doses.", "population_specificity": "General discussion (no specific population studied)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.290701+00:00"}
{"study_id": 71686, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "To evaluate the potential benefit of levocarnitine supplementation for cancer-related fatigue in patients treated with sunitinib.", "results_summary": "Seven out of ten patients with worsened fatigue after sunitinib therapy showed improvement in serum carnitine levels and fatigue scores after 2-week L-carnitine supplementation. Six of these seven patients (85.7%) demonstrated reduced fatigue scores at 4 weeks compared to 2 weeks.", "population_specificity": "Patients with unresectable or metastatic renal cell carcinoma treated with sunitinib.", "effective_dosage": "Not specified for L-carnitine (sunitinib doses were 37.5 mg or 50 mg/day).", "study_duration": "2 weeks of L-carnitine supplementation.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:11.637735+00:00"}
{"study_id": 71688, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare serum L-carnitine and 25(OH)D levels between men with erectile dysfunction (ED) non-responsive to oral sildenafil citrate and healthy volunteers.", "results_summary": "The study found that men with ED non-responsive to sildenafil citrate had significantly lower serum L-carnitine levels compared to healthy controls, and L-carnitine levels positively correlated with erectile function scores and vitamin D levels.", "population_specificity": "192 men (96 with ED non-responsive to sildenafil citrate and 96 healthy controls) recruited from two University Hospitals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:12.038450+00:00"}
{"study_id": 71690, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of L-Carnitine treatment on energy metabolism, specifically fatty acid oxidation, during exercise in patients with primary carnitine deficiency (PCD).", "results_summary": "L-Carnitine treatment significantly increased fatty acid oxidation rates during exercise in PCD patients compared to no treatment, though rates remained lower than in healthy controls. The study suggests L-Carnitine may improve skeletal muscle fat metabolism during exercise in PCD patients.", "population_specificity": "Eight adults with PCD homozygous for the c.95A>G mutation and 10 healthy age- and sex-matched controls.", "effective_dosage": "Not specified", "study_duration": "Four-day pause in treatment (intervention period)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:14.891625+00:00"}
{"study_id": 71691, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the clinical features and management practices of Primary Carnitine Deficiency (PCD), including the effectiveness of high-dose L-Carnitine supplementation.", "results_summary": "The study found that high-dose L-Carnitine is an effective intervention for patients with PCD, improving clinical outcomes. It also highlighted potential contraindicated treatments and discussed mechanistic insights from preclinical studies.", "population_specificity": "Patients with Primary Carnitine Deficiency (PCD), Neutral Lipid Storage Disease (NLSD), and Multiple Acyl-CoA Dehydrogenase Deficiency (MADD).", "effective_dosage": "High dosage (specific amount not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:15.643715+00:00"}
{"study_id": 71675, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effect of L-Carnitine supplementation on lipid profile and glycaemic control in adults with cardiovascular risk factors through a meta-analysis of randomized clinical trials.", "results_summary": "The meta-analysis found that L-Carnitine significantly improved total cholesterol, LDL-C, HDL-C, Lp(a), fasting plasma glucose, HbA1C, and HOMA-IR, but had no effect on triglycerides, Apo A-I, or Apo B 100. The benefits were more pronounced at doses exceeding 1500 mg/day and when combined with a hypocaloric diet.", "population_specificity": "Adults with cardiovascular risk factors.", "effective_dosage": "More than 1500 mg/day (most effective dosage).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:16.347044+00:00"}
{"study_id": 71692, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate whether acetyl-l-carnitine (LAC) levels could serve as a biomarker for major depressive disorder (MDD) and whether LAC supplementation could have antidepressant effects.", "results_summary": "The study found that LAC levels were significantly decreased in MDD patients compared to healthy controls, with greater deficiency linked to more severe symptoms, earlier onset, and treatment-resistant depression. LAC supplementation showed rapid and lasting antidepressant-like effects in rodents via epigenetic mechanisms.", "population_specificity": "Patients with major depressive disorder (MDD), including those with treatment-resistant depression (TRD), and healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:18.140280+00:00"}
{"study_id": 71695, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of L-Carnitine supplementation on sperm function in oligoasthenospermic men, comparing it to other treatments.", "results_summary": "The study found that L-Carnitine (Group B) was part of the comparison but did not report specific improvements in sperm motility, HOST results, or hyperactivated spermatozoa for this group, unlike the other treatment groups.", "population_specificity": "Oligoasthenospermic men (n=44 in Group B).", "effective_dosage": "Not specified in the abstract.", "study_duration": "90 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:18.888646+00:00"}
{"study_id": 71694, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the efficacy of spirulina supplement combined with conventional therapy (including L-Carnitine) on semen parameters and pregnancy rates in men with idiopathic infertility.", "results_summary": "The study found no significant differences in semen parameters between the spirulina and control groups, though a modest pregnancy rate (5%) was observed in the spirulina group versus 0% in the control group. L-Carnitine was part of the conventional therapy but its individual effects were not isolated.", "population_specificity": "40 men with idiopathic infertility.", "effective_dosage": "500 mg/day L-Carnitine.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.136226+00:00"}
{"study_id": 71696, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential role of L-Carnitine in sepsis, particularly its suspected benefits in septic shock.", "results_summary": "The study suggests L-Carnitine may be beneficial for patients in septic shock, though clinical trials are ongoing to validate its standard use. The abstract does not provide specific efficacy data but implies potential therapeutic value.", "population_specificity": "Septic patients, specifically those in septic shock.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:19.142194+00:00"}
{"study_id": 71693, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of L-acetyl-carnitine (LAC) as a preventive treatment for Chemotherapy-Induced Peripheral Neuropathy (CIPN) in cancer patients.", "results_summary": "LAC showed beneficial effects in animal and in vitro studies, but clinical trial results were mixed. It improved CIPN symptoms in patients treated with platinum compounds but showed no benefit for those treated with Taxanes.", "population_specificity": "Cancer patients experiencing CIPN, specifically those treated with platinum compounds or Taxanes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:20.072698+00:00"}
{"study_id": 71698, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to identify dietary supplements, including acetyl-L-carnitine, that improve fatigue in patients with breast cancer.", "results_summary": "Acetyl-L-carnitine was among the most commonly used supplements found to improve fatigue in breast cancer patients, with studies showing low risk of bias and high-quality evidence supporting its efficacy.", "population_specificity": "Women diagnosed with breast cancer experiencing cancer-related fatigue.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:22.227361+00:00"}
{"study_id": 71699, "supplement_id": 1266, "safety_score": "20", "efficacy_score": 10, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of acetyl-L-carnitine in preventing chemotherapy-induced peripheral neuropathy in breast cancer patients.", "results_summary": "The study found that acetyl-L-carnitine is not recommended for preventing chemotherapy-induced peripheral neuropathy due to a possibility of harm. No strong evidence supports its use for managing breast cancer treatment-related adverse effects.", "population_specificity": "Breast cancer patients undergoing chemotherapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:22.945875+00:00"}
{"study_id": 71697, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to review the potential benefits of prophylactic L-carnitine administration in the parenteral nutrition of preterm newborns to address carnitine deficiency and improve lipid tolerance.", "results_summary": "The study found that L-carnitine supplementation increased plasma carnitine levels but did not significantly improve lipid profiles, weight gain, morbidity, mortality, or hospital stay duration. More research is needed to determine clinical benefits for long-term parenteral nutrition in preterm infants.", "population_specificity": "Preterm newborns receiving total parenteral nutrition.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:23.740001+00:00"}
{"study_id": 71701, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of L-Carnitine (LC) and its derivatives in managing metabolic and clinical parameters associated with Type 2 Diabetes (T2D).", "results_summary": "The study summarizes evidence suggesting that LC supplementation may improve lipid metabolism and oxidative stress in T2D, potentially aiding in disease management. Results from animal and clinical studies indicate positive effects on metabolic parameters.", "population_specificity": "Individuals with Type 2 Diabetes (animal and clinical studies reviewed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:25.185459+00:00"}
{"study_id": 71703, "supplement_id": 1266, "safety_score": "80", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers aimed to determine whether L-Carnitine reduces neuron-specific enolase (NSE) levels and improves neurocognitive outcomes in patients with traumatic brain injury (TBI).", "results_summary": "L-Carnitine improved neurobehavioral function and reduced cerebral edema but did not significantly affect NSE levels or mortality rates compared to placebo. Attention deficit was more frequent in the L-Carnitine group.", "population_specificity": "Forty patients with severe traumatic brain injury (TBI).", "effective_dosage": "2g/day", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:26.441323+00:00"}
{"study_id": 71702, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to compare the efficacy, tolerability, and safety of duloxetine versus L-carnitine in the treatment of fibromyalgia in adults.", "results_summary": "The study found no significant difference in efficacy, tolerability, or safety between duloxetine and L-carnitine, though the evidence was of very low quality due to concerns about publication bias, imprecision, and indirectness.", "population_specificity": "Adults with fibromyalgia.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:26.497787+00:00"}
{"study_id": 71704, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of L-carnitine supplementation on serum leptin levels through a meta-analysis of randomized controlled trials.", "results_summary": "L-carnitine supplementation did not significantly affect serum leptin concentrations overall, but a significant effect was observed in diabetic patients and those receiving doses over 3 mg per day for less than 12 weeks.", "population_specificity": "325 cases and 330 controls from seven studies, including diabetic patients.", "effective_dosage": "Doses more than 3 mg per day.", "study_duration": "Less than 12 weeks.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:26.558124+00:00"}
{"study_id": 71705, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of extended duration nocturnal hemodialysis on metabolite profiles, including L-Carnitine, in patients with kidney disease.", "results_summary": "The study found that L-Carnitine and acetylcarnitine levels decreased after conversion to nocturnal hemodialysis, suggesting altered metabolism or clearance. No significant changes were observed in the conventional hemodialysis group.", "population_specificity": "33 patients receiving conventional thrice-weekly hemodialysis who converted to nocturnal hemodialysis, and 20 control patients who remained on conventional hemodialysis.", "effective_dosage": "Not specified", "study_duration": "52 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:28.264412+00:00"}
{"study_id": 71707, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of L-carnitine (LC) and acetyl L-carnitine (ALC) on female fertility, including their mechanisms of action and potential benefits.", "results_summary": "LC and ALC improve female fertility by reducing cellular stress, maintaining hormonal balance, enhancing energy production, and protecting against oxidative damage. ALC is preferred for its antioxidant properties, while LC is better for energy supply.", "population_specificity": "Female reproductive system (human, animal, and assisted reproductive technology studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:30.636650+00:00"}
{"study_id": 71708, "supplement_id": 1266, "safety_score": "30", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to investigate the long-term effects of Acetyl-L-carnitine (ALC) on chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer patients undergoing taxane-based chemotherapy.", "results_summary": "The study found that ALC significantly worsened CIPN compared to placebo, with persistent negative effects observed at 24, 36, and 52 weeks. At 104 weeks, both groups showed reduced neurotoxicity scores, but the ALC group had a higher proportion of patients reporting significant worsening.", "population_specificity": "Women with breast cancer undergoing adjuvant taxane-based chemotherapy.", "effective_dosage": "1000 mg three times a day.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:33.454690+00:00"}
{"study_id": 71709, "supplement_id": 1266, "safety_score": "95", "efficacy_score": 90, "quality_score": 70, "study_goal": "The researchers aimed to assess the role of L-carnitine in treating valproic acid-induced hyperammonemic encephalopathy (VPE) in pediatric patients.", "results_summary": "The study found that intravenous L-carnitine (100-200 mg/kg/day) led to full recovery in all 13 cases of VPE, with no reported adverse effects or toxicity.", "population_specificity": "Pediatric patients with VPA-induced hyperammonemic encephalopathy.", "effective_dosage": "100 mg/kg/day (divided every 8 hours) or 200 mg/kg/day (single case).", "study_duration": "Until clinical improvement occurred (exact duration not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:33.577414+00:00"}
{"study_id": 71711, "supplement_id": 1266, "safety_score": "80", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the effectiveness of acetyl-L-carnitine (ALC) supplementation in reducing depressive symptoms compared to placebo/no intervention and established antidepressants.", "results_summary": "ALC significantly reduced depressive symptoms compared to placebo/no intervention and showed similar effectiveness to antidepressants with fewer adverse effects. The effect was most pronounced in older adults.", "population_specificity": "791 participants (mean age = 54 years, 65% female) with depressive symptoms.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:33.909242+00:00"}
{"study_id": 71710, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of glycine in metabolic pathways, including its synthesis during endogenous L-carnitine production, and its potential implications in diabetes and cardiovascular disease.", "results_summary": "The study highlights glycine's involvement in multiple metabolic processes, including L-carnitine synthesis, and suggests a link between glycine deficiency and increased risk of type 2 diabetes and vascular complications. However, it does not directly assess L-carnitine's effects.", "population_specificity": "Patients with obesity, diabetes, or chronic kidney disease, and lean offspring of parents with type 2 diabetes.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:34.537801+00:00"}
{"study_id": 71713, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 30, "study_goal": "The researchers aimed to evaluate the role of L-Carnitine in treating valproic acid overdose, particularly its impact on electrocardiographic changes and overall toxicity management.", "results_summary": "The study mentions L-Carnitine as a potential treatment for valproic acid overdose but does not provide specific efficacy data. It suggests L-Carnitine may help address metabolic abnormalities but lacks detailed results on its effectiveness.", "population_specificity": "Adolescent with acute valproic acid overdose.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.616082+00:00"}
{"study_id": 71712, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the anti-ischemic properties of L-carnitine and its derivatives in noncardiac organs, focusing on their potential to mitigate ischemia-reperfusion injury.", "results_summary": "The study found that L-carnitine and its derivatives showed protective effects against ischemia-reperfusion injury in noncardiac organs, likely due to antioxidant and anti-inflammatory properties, though more clinical trials are needed to confirm its clinical relevance.", "population_specificity": "Animal and human research (non-specific population details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:35.994986+00:00"}
{"study_id": 71706, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether oral L-Carnitine supplementation improves embryo quality and implantation potential in fertility patients undergoing IVF-ET.", "results_summary": "L-Carnitine administration improved embryo quality on Days 3 and 5 post-insemination, though it did not affect oocyte retrieval, maturation, or fertilization rates. Healthy neonates were born following L-Carnitine supplementation.", "population_specificity": "214 patients with prior IVF-ET failure attempting conception again.", "effective_dosage": "Not specified", "study_duration": "82 days on average", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:38.154728+00:00"}
{"study_id": 71714, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to evaluate the effect of L-carnitine on postoperative atrial fibrillation (AF), C-reactive protein (CRP) levels, and acute kidney injury following coronary artery bypass graft surgery (CABG).", "results_summary": "L-carnitine reduced the incidence of postoperative AF (7.5% vs. 19.4% in controls) and lowered CRP levels, indicating reduced inflammation. No significant effect was observed on acute kidney injury markers.", "population_specificity": "134 patients undergoing elective CABG without prior AF or L-carnitine treatment.", "effective_dosage": "3000 mg/d L-carnitine.", "study_duration": "Administered before surgery (exact duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:39.379850+00:00"}
{"study_id": 71716, "supplement_id": 1266, "safety_score": "80", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic effect of L-Carnitine in treating fatigue symptoms in multiple sclerosis (MS) patients compared to other medications.", "results_summary": "The study found that L-Carnitine might have a similar therapeutic effect to amantadine for MS-related fatigue, but the reliability of this finding was limited by small sample sizes. All drugs except pemoline were considered relatively safe for treating MS fatigue.", "population_specificity": "Patients with multiple sclerosis experiencing fatigue.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:41.113451+00:00"}
{"study_id": 71715, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 60, "study_goal": "The researchers aimed to determine whether L-Carnitine could effectively reduce hyperammonemia caused by Valproic acid therapy in a bipolar disorder patient.", "results_summary": "L-Carnitine administration rapidly reduced ammonia levels from 594\u200a\u03bcg/dL to 99\u200a\u03bcg/dL within 12 hours and restored mental status within 24 hours, demonstrating strong efficacy in resolving Valproic acid-induced hyperammonemia.", "population_specificity": "A 29-year-old man with bipolar disorder and substance use disorder experiencing Valproic acid-induced hyperammonemia.", "effective_dosage": "4.5\u200ag/day intravenously.", "study_duration": "24 hours (until mental status restoration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:42.034376+00:00"}
{"study_id": 71717, "supplement_id": 1266, "safety_score": "30", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety and therapeutic potential of L-carnitine combined with valproic acid (VPA) in infants with spinal muscular atrophy (SMA) type I.", "results_summary": "The study found that L-carnitine/VPA was ineffective at altering survival in infants with SMA type I, with a high rate of adverse events (95% of subjects), including respiratory events and deaths. Survival outcomes did not significantly differ between treated and untreated cohorts.", "population_specificity": "Infants with spinal muscular atrophy (SMA) type I.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:42.081078+00:00"}
{"study_id": 71718, "supplement_id": 1266, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the effect of L-carnitine on insulin resistance (IR) in patients using HOMA-IR as a clinical evaluation metric.", "results_summary": "The meta-analysis found that L-carnitine was useful in treating IR, with significant improvements in HOMA-IR scores (WMD -0.724, p < 0.0001). Efficacy increased with prolonged treatment duration, though more long-term RCTs are needed for confirmation.", "population_specificity": "Patients with insulin resistance (HOMA-IR).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Evaluated at 3, 6, 9, and 12 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:42.571622+00:00"}
{"study_id": 24875, "supplement_id": 1297, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy of a low-FODMAP diet compared to other diets in reducing gastrointestinal symptoms, assessing nutrient intake, and improving quality of life in adults and children with irritable bowel syndrome.", "results_summary": "The study found significant evidence that a low-FODMAP diet may effectively reduce stomach discomfort, pain, bloating, and improve quality of life for irritable bowel syndrome patients. The diet was compared against other dietary strategies, showing favorable outcomes.", "population_specificity": "Adults and children with irritable bowel syndrome.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:51.205668+00:00"}
{"study_id": 24873, "supplement_id": 1297, "safety_score": "75", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the evidence for the low-FODMAP diet's effectiveness in managing IBS symptoms, focusing on restriction, reintroduction, and long-term clinical management.", "results_summary": "The low-FODMAP diet shows superior symptom response compared to control diets and is more effective than other dietary treatments for IBS. However, research on reintroduction and personalization is limited, and dietitian-led education is preferred but not always available.", "population_specificity": "Patients with irritable bowel syndrome (IBS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:51.288641+00:00"}
{"study_id": 24874, "supplement_id": 1297, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if baseline fecal microbiota or metabolite profiles could predict clinical response to a Low-FODMAP Diet (LFD) in IBS patients.", "results_summary": "The study found that clinical response rates were 50% for LFD alone and 67% for LFD supplemented with B-GOS, compared to 30% in controls. Baseline fecal propionate and urine metabolite profiles predicted response in the LFD group.", "population_specificity": "Adults fulfilling Rome III criteria for irritable bowel syndrome (IBS).", "effective_dosage": "1.8 g/d B-galactooligosaccharide (B-GOS) for the supplemented group.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:51.702181+00:00"}
{"study_id": 24877, "supplement_id": 1297, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential therapeutic role of the Low-FODMAP Diet (LFD) in managing functional dyspepsia (FD), either alone or in combination with other therapies.", "results_summary": "Emerging evidence suggests FODMAPs may contribute to FD pathogenesis, and recent clinical trials indicate the LFD could be beneficial for FD patients, particularly those with post-prandial distress syndrome (PDS). The abstract highlights the diet's potential but notes limited evidence supporting dietary interventions for FD.", "population_specificity": "Patients with functional dyspepsia (FD), particularly those with post-prandial distress syndrome (PDS).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:21:51.914666+00:00"}
